| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 KIF19 KIF5C KIF11 DNHD1 DNAH7 DNAH1 MYH14 DNAH11 | 1.73e-10 | 118 | 242 | 14 | GO:0003774 |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.23e-07 | 38 | 242 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 DDX5 MDN1 KIF19 KIF5C KIF11 DHX16 DNHD1 CECR2 YTHDC2 FANCM DNAH7 DNAH1 ABCG1 MYH14 IGHMBP2 SNRNP200 DNAH11 | 1.80e-06 | 614 | 242 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | GTPase binding | MYO5A MYO5B RGPD1 UNC13D RABGAP1L FMNL1 RABGGTA WDR44 CIB1 DOCK10 TRIOBP SRGAP2 DOCK7 PKN1 ENO1 XPO7 | 8.90e-06 | 360 | 242 | 16 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | MYO5A MYO5B RGPD1 UNC13D RABGAP1L FMNL1 RABGGTA WDR44 CIB1 DOCK10 TRIOBP SRGAP2 DOCK7 PKN1 XPO7 | 9.43e-06 | 321 | 242 | 15 | GO:0031267 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.20e-05 | 70 | 242 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RALGAPA1 TBC1D2 TBC1D2B RGPD1 OBSCN GMIP RABGAP1L ALDH1A1 PLXNB1 TBXA2R TBC1D15 DOCK10 ARHGEF12 SRGAP2 ARHGEF33 ARHGEF1 DOCK7 SOS2 | 4.99e-05 | 507 | 242 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RALGAPA1 TBC1D2 TBC1D2B RGPD1 OBSCN GMIP RABGAP1L ALDH1A1 PLXNB1 TBXA2R TBC1D15 DOCK10 ARHGEF12 SRGAP2 ARHGEF33 ARHGEF1 DOCK7 SOS2 | 4.99e-05 | 507 | 242 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.63e-05 | 18 | 242 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 SPTAN1 SPIRE1 PTK2 FMN1 SYNE2 KCNMA1 DMD FMNL1 SYNE1 TRIOBP MYH14 | 8.13e-05 | 479 | 242 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 SPTAN1 FMNL1 SYNE1 TRIOBP MYH14 | 1.07e-04 | 227 | 242 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 SPTAN1 OBSCN DDX5 EEA1 MYH14 | 1.21e-04 | 230 | 242 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | GTPase activator activity | RALGAPA1 TBC1D2 TBC1D2B RGPD1 GMIP RABGAP1L ALDH1A1 PLXNB1 TBC1D15 ARHGEF12 SRGAP2 ARHGEF1 | 1.62e-04 | 279 | 242 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 MYOC SPTAN1 OBSCN SPIRE1 PTK2 FMN1 SYNE2 KIF19 KCNMA1 FAM83D KIF5C DMD FMNL1 KIF11 KRT2 KRT10 SYNE1 TRIOBP PKD2L1 APOE MYH14 NIN | 1.68e-04 | 1099 | 242 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | structural molecule activity | MYH11 SPTAN1 OBSCN MRPL19 GFAP BGN KRT40 KRT20 DMD IMPG2 KRT2 KRT10 KRT13 RAPSN KRT15 KRT17 NUP107 SEPTIN4 KRT34 NUP88 LAMA3 APOE SRBD1 MRPS14 | 2.24e-04 | 891 | 242 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.43e-04 | 28 | 242 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.69e-04 | 78 | 242 | 6 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.23e-04 | 80 | 242 | 6 | GO:0008186 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA oxidase activity | 8.64e-04 | 4 | 242 | 2 | GO:0016401 | |
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 8.64e-04 | 4 | 242 | 2 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 8.64e-04 | 4 | 242 | 2 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 8.64e-04 | 4 | 242 | 2 | GO:0004619 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.02e-03 | 37 | 242 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYO5B DDX5 MDN1 KIF19 KIF5C DHX16 YTHDC2 FANCM DNAH7 ABCG1 IGHMBP2 SNRNP200 DNAH11 | 1.03e-03 | 441 | 242 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.05e-03 | 17 | 242 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.43e-03 | 5 | 242 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.43e-03 | 5 | 242 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH3 MYH11 MYO5A MYO5B MYOC USP9X SPTAN1 OBSCN SPIRE1 HAUS3 GFAP FAT1 FMN1 P3H1 KRT40 KIF19 KRT20 FCHSD1 SPATC1L KRT2 KRT10 KRT13 CIB1 KRT15 KRT17 KRT34 TRIOBP APOE CIT VIPAS39 ARHGEF1 PDE4DIP NIN | 2.33e-08 | 957 | 240 | 33 | GO:0097435 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.17e-07 | 75 | 240 | 9 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.38e-07 | 99 | 240 | 10 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.61e-07 | 100 | 240 | 10 | GO:0045103 | |
| GeneOntologyBiologicalProcess | synapse organization | FILIP1 MYO5A MYO5B USP9X CC2D1A PTK2 PCDH17 NRXN2 SLITRK6 ADGRF1 PLXNB1 AMIGO2 SEMA3F CUX2 RAPSN PPFIA4 DOCK10 CNKSR2 SRGAP2 APOE SHISA7 DOCK7 SRGAP2B CDH9 | 1.68e-06 | 685 | 240 | 24 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron projection development | MYO5B MYOC USP9X HLA-F SPIRE1 CC2D1A TENM2 GFAP NCDN PTK2 SLC12A5 TLX2 P3H1 ADAM17 KIF5C DMD SLITRK6 ADGRF1 PLXNB1 SEMA3F PLXNA3 FAT4 CUX2 CIB1 NEDD4L SYNE1 CECR2 DOCK10 LAMA3 TRIOBP SRGAP2 APOE CIT DOCK7 NIN | 2.35e-06 | 1285 | 240 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYO5B MYO10 USP9X CC2D1A TENM2 PTK2 TLX2 FAT1 ADAM17 KIF5C DMD SLITRK6 FMNL1 PLXNB1 SEMA3F PLXNA3 CUX2 CIB1 NEDD4L SYNE1 DOCK10 LAMA3 TRIOBP SRGAP2 APOE CDH19 CIT MYH14 DOCK7 PRKDC ZRANB1 CDH9 NIN | 3.47e-06 | 1194 | 240 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction organization | FILIP1 MYO5A MYO5B MYOC USP9X CC2D1A PTK2 PCDH17 NRXN2 FMN1 SLITRK6 ADGRF1 PLXNB1 AMIGO2 SEMA3F CUX2 RAPSN NEDD4L PPFIA4 DOCK10 LAMA3 CNKSR2 SRGAP2 APOE CDH19 SHISA7 DOCK7 SRGAP2B CDH9 | 3.48e-06 | 974 | 240 | 29 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse assembly | USP9X CC2D1A PTK2 PCDH17 NRXN2 SLITRK6 ADGRF1 PLXNB1 AMIGO2 CUX2 DOCK10 SRGAP2 DOCK7 SRGAP2B CDH9 | 3.53e-06 | 308 | 240 | 15 | GO:0007416 |
| GeneOntologyBiologicalProcess | neuron development | MYO5B MYOC USP9X HLA-F SPIRE1 CC2D1A TENM2 GFAP NCDN PTK2 SLC12A5 TLX2 P3H1 KCNMA1 ADAM17 KIF5C DMD SLITRK6 ADGRF1 PLXNB1 SEMA3F PLXNA3 FAT4 CUX2 CIB1 NEDD4L SYNE1 CECR2 DOCK10 LAMA3 TRIOBP SRGAP2 APOE CIT PALS1 DOCK7 NIN | 6.46e-06 | 1463 | 240 | 37 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell junction assembly | MYOC USP9X CC2D1A PTK2 PCDH17 NRXN2 FMN1 SLITRK6 ADGRF1 PLXNB1 AMIGO2 CUX2 NEDD4L DOCK10 LAMA3 SRGAP2 CDH19 DOCK7 SRGAP2B CDH9 | 1.22e-05 | 569 | 240 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MYO5B MYO10 TBC1D2 TBC1D2B HLA-F TENM2 GFAP PTK2 TLX2 P3H1 SYNE2 ADAM17 DMD PLXNB1 WDR44 SEMA3F PLXNA3 TBC1D15 CUX2 CIB1 NEDD4L SYNE1 APOE CIT NIN | 1.95e-05 | 846 | 240 | 25 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MYO5B MYO10 TBC1D2 TBC1D2B HLA-F TENM2 GFAP PTK2 TLX2 P3H1 SYNE2 ADAM17 DMD PLXNB1 WDR44 SEMA3F PLXNA3 TBC1D15 CUX2 CIB1 NEDD4L SYNE1 APOE CIT NIN | 2.71e-05 | 863 | 240 | 25 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | MYO5B MYO10 MYOC USP9X SPTAN1 TBC1D2 TBC1D2B CC2D1A HAUS3 IKZF1 TENM2 GFAP PTK2 NRXN2 FMN1 SYNE2 SLITRK6 FCHSD1 WDR44 AMIGO2 TBC1D15 CUX2 NEDD4L SYNE1 DOCK10 TRIOBP SRGAP2 APOE PDE4DIP SRGAP2B | 5.55e-05 | 1189 | 240 | 30 | GO:0044087 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYO5B USP9X CC2D1A TENM2 PTK2 TLX2 ADAM17 KIF5C DMD SLITRK6 PLXNB1 SEMA3F PLXNA3 CUX2 NEDD4L SYNE1 DOCK10 LAMA3 SRGAP2 APOE CIT DOCK7 NIN | 6.71e-05 | 802 | 240 | 23 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYO5B USP9X CC2D1A TENM2 PTK2 TLX2 ADAM17 KIF5C SLITRK6 PLXNB1 SEMA3F PLXNA3 CUX2 NEDD4L SYNE1 DOCK10 LAMA3 TRIOBP APOE CIT DOCK7 NIN | 6.73e-05 | 748 | 240 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | MYOC USP9X CC2D1A PTK2 NRXN2 FMN1 SLITRK6 AMIGO2 CUX2 NEDD4L DOCK10 SRGAP2 SRGAP2B | 7.23e-05 | 309 | 240 | 13 | GO:1901888 |
| GeneOntologyBiologicalProcess | anatomical structure arrangement | 9.16e-05 | 21 | 240 | 4 | GO:0048532 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYO5B USP9X CC2D1A TENM2 PTK2 TLX2 ADAM17 KIF5C DMD SLITRK6 PLXNB1 SEMA3F PLXNA3 CUX2 NEDD4L SYNE1 DOCK10 LAMA3 SRGAP2 APOE CIT DOCK7 NIN | 9.19e-05 | 819 | 240 | 23 | GO:0120039 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | HLA-F GFAP PTK2 TLX2 ADAM17 WDR44 SEMA3F PLXNA3 CIB1 APOE CIT | 9.48e-05 | 233 | 240 | 11 | GO:0031345 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYO5B USP9X CC2D1A TENM2 PTK2 TLX2 ADAM17 KIF5C DMD SLITRK6 PLXNB1 SEMA3F PLXNA3 CUX2 NEDD4L SYNE1 DOCK10 LAMA3 SRGAP2 APOE CIT DOCK7 NIN | 1.04e-04 | 826 | 240 | 23 | GO:0048858 |
| GeneOntologyBiologicalProcess | microtubule-based process | STAG1 MYO5A NEK10 SPIRE1 CC2D1A HAUS3 PTK2 SYNE2 KIF19 PGAM4 KATNIP KIF5C AP3D1 KIF11 DNHD1 CIB1 SEPTIN4 SRGAP2 DNAH7 DNAH1 ARHGEF1 PDE4DIP DOCK7 IFT122 CCDC63 DNAH11 NIN | 1.11e-04 | 1058 | 240 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of substrate adhesion-dependent cell spreading | 1.18e-04 | 66 | 240 | 6 | GO:1900024 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 1.23e-04 | 95 | 240 | 7 | GO:0006081 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | USP9X CC2D1A PTK2 NRXN2 SLITRK6 AMIGO2 CUX2 DOCK10 SRGAP2 SRGAP2B | 1.34e-04 | 202 | 240 | 10 | GO:0051963 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 MYH11 STAG1 USP9X TBC1D2 TBC1D2B OBSCN HAUS3 MDN1 NRXN2 SYNE2 NLE1 CPLANE1 NOP2 AP3D1 KIF11 WDR44 DNHD1 TBC1D15 SYNE1 DNAH7 DNAH1 PTPDC1 VIPAS39 DOCK7 IFT122 PRKDC CCDC63 | 1.52e-04 | 1138 | 240 | 28 | GO:0070925 |
| GeneOntologyBiologicalProcess | nucleus localization | 1.53e-04 | 44 | 240 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | RALGAPA1 TBC1D2 TBC1D2B GMIP PTK2 SNX13 RABGAP1L PLXNB1 PLXNA3 TBC1D15 DOCK10 SRGAP2 DOCK7 | 1.62e-04 | 335 | 240 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of substrate adhesion-dependent cell spreading | 1.90e-04 | 46 | 240 | 5 | GO:1900026 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | MYO5B PTK2 ADAM17 CIB1 NEDD4L KRT17 APOE KLHL22 CSNK2A1 CSNK2A3 | 2.06e-04 | 213 | 240 | 10 | GO:0030307 |
| GeneOntologyBiologicalProcess | microtubule-based movement | MYO5A NEK10 SYNE2 KIF19 PGAM4 KATNIP KIF5C AP3D1 KIF11 DNHD1 SEPTIN4 DNAH7 DNAH1 IFT122 CCDC63 DNAH11 | 2.29e-04 | 493 | 240 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | actin filament-based transport | 2.40e-04 | 11 | 240 | 3 | GO:0099515 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 2.88e-04 | 109 | 240 | 7 | GO:0034446 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | MYO5B HLA-F GFAP PTK2 TLX2 P3H1 ADAM17 DMD PLXNB1 SEMA3F PLXNA3 CUX2 CIB1 NEDD4L SYNE1 APOE CIT NIN | 3.13e-04 | 612 | 240 | 18 | GO:0010975 |
| GeneOntologyBiologicalProcess | postsynapse organization | MYO5B USP9X CC2D1A NRXN2 SEMA3F CUX2 RAPSN DOCK10 CNKSR2 APOE SHISA7 DOCK7 | 3.21e-04 | 313 | 240 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 3.64e-04 | 149 | 240 | 8 | GO:0010811 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 4.01e-04 | 3 | 240 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | cranial nerve structural organization | 4.08e-04 | 13 | 240 | 3 | GO:0021604 | |
| GeneOntologyBiologicalProcess | glyceraldehyde-3-phosphate biosynthetic process | 4.08e-04 | 13 | 240 | 3 | GO:0046166 | |
| GeneOntologyBiologicalProcess | cilium organization | USP9X TBC1D2 TBC1D2B SYNE2 KIF19 CPLANE1 WDR44 DNHD1 TBC1D15 SYNE1 DNAH7 DNAH1 PTPDC1 IFT122 CCDC63 | 4.88e-04 | 476 | 240 | 15 | GO:0044782 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MYH3 MYH11 MYO5A SPTAN1 LRRC49 OBSCN HAUS3 GFAP FMN1 SYNE2 KRT40 KIF19 KRT20 KIF5C DMD KIF11 WDR44 KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 SYNE1 APOE DNAH7 FAM83H KLHL22 DNAH1 MYH14 PDE4DIP ENO1 DNAH11 NIN | 2.37e-07 | 1179 | 240 | 35 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MYH3 MYH11 MYO5A SPTAN1 LRRC49 OBSCN HAUS3 GFAP FMN1 SYNE2 KRT40 KIF19 KRT20 KIF5C DMD KIF11 WDR44 KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 SYNE1 APOE DNAH7 FAM83H KLHL22 DNAH1 MYH14 PDE4DIP ENO1 DNAH11 NIN | 2.78e-07 | 1187 | 240 | 35 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | MYO5A GFAP MDN1 SYNE2 KRT40 KRT20 DMD KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 FAM83H | 2.31e-06 | 263 | 240 | 14 | GO:0045111 |
| GeneOntologyCellularComponent | myosin complex | 4.95e-06 | 59 | 240 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 8.43e-06 | 25 | 240 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | intermediate filament | MYO5A GFAP KRT40 KRT20 DMD KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 FAM83H | 1.32e-05 | 227 | 240 | 12 | GO:0005882 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO5A LRRC49 HAUS3 GFAP FMN1 KRT40 KIF19 KRT20 KIF5C DMD KIF11 WDR44 KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 APOE DNAH7 FAM83H KLHL22 DNAH1 PDE4DIP DNAH11 NIN | 1.52e-05 | 899 | 240 | 26 | GO:0099513 |
| GeneOntologyCellularComponent | glutamatergic synapse | FILIP1 MYO5A MYO5B SPTAN1 CC2D1A TENM2 NCDN PTK2 PCDH17 NRXN2 KCNMA1 EEA1 AP3D1 SEMA3F NEDD4L PPFIA4 DOCK10 CNKSR2 SRGAP2 APOE SHISA7 SRGAP2B CDH9 | 7.26e-05 | 817 | 240 | 23 | GO:0098978 |
| GeneOntologyCellularComponent | actin cytoskeleton | FILIP1 MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 SPTAN1 DGKH PTK2 FMN1 ADAM17 FCHSD1 ANKRD26 TRIOBP PKD2L1 CIT MYH14 | 1.27e-04 | 576 | 240 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | inner dynein arm | 1.69e-04 | 10 | 240 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | myelin sheath | MYOC SPTAN1 PGAM1 GFAP PGAM4 UQCRC1 SEPTIN4 PALS1 MYH14 ENO1 | 2.15e-04 | 217 | 240 | 10 | GO:0043209 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD1 XAB2 DDX5 DMAP1 FANCA SYNE2 ASCC2 AFF1 MGA SMG6 INO80E DHX16 GCFC2 POLR1A NUP107 MAFK SYNE1 CECR2 NUP88 BAZ1B CASP8 E2F1 FANCM TEP1 NFE2L3 CSNK2A1 DOCK7 PRKDC NHEJ1 SNRNP200 XPO7 | 2.55e-04 | 1377 | 240 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | axon | MYO5A MYOC USP9X SPTAN1 TENM2 NCDN KCNMA1 KIF5C ALDH1A1 EEA1 DMD AP3D1 CAD CIB1 SEPTIN4 PALS1 MYH14 IGHMBP2 DOCK7 ENO1 CDH9 UNC80 NIN | 2.58e-04 | 891 | 240 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | myosin II complex | 2.79e-04 | 28 | 240 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | distal axon | MYO5A USP9X TENM2 KCNMA1 KIF5C AP3D1 CAD CIB1 SEPTIN4 MYH14 IGHMBP2 DOCK7 ENO1 NIN | 5.36e-04 | 435 | 240 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | filopodium | 5.53e-04 | 123 | 240 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.59e-04 | 161 | 240 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | growth cone | 5.61e-04 | 245 | 240 | 10 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.19e-04 | 253 | 240 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | muscle myosin complex | 7.49e-04 | 16 | 240 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 7.76e-04 | 4 | 240 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.12e-03 | 40 | 240 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.26e-03 | 19 | 240 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | filopodium tip | 1.47e-03 | 20 | 240 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.71e-03 | 21 | 240 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYO5A MYO5B MYO10 TENM2 NCDN PTK2 SLC12A5 TRPM5 KCNMA1 KIF5C DMD FCHSD1 CAD CIB1 SEPTIN4 SYNE1 DOCK10 CNKSR2 SRGAP2 APOE CIT SHISA7 PALS1 IGHMBP2 CDH9 NIN | 1.96e-03 | 1228 | 240 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.00e-03 | 290 | 240 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | DNA repair complex | 2.23e-03 | 23 | 240 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | cell division site | 2.29e-03 | 80 | 240 | 5 | GO:0032153 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 2.65e-03 | 7 | 240 | 2 | GO:0005958 | |
| Domain | Keratin_I | 7.87e-08 | 44 | 240 | 8 | IPR002957 | |
| Domain | IF | 3.46e-07 | 72 | 240 | 9 | PS00226 | |
| Domain | Filament | 3.90e-07 | 73 | 240 | 9 | PF00038 | |
| Domain | Myosin_head_motor_dom | 4.76e-07 | 38 | 240 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.76e-07 | 38 | 240 | 7 | PS51456 | |
| Domain | Myosin_head | 4.76e-07 | 38 | 240 | 7 | PF00063 | |
| Domain | MYSc | 4.76e-07 | 38 | 240 | 7 | SM00242 | |
| Domain | IF | 5.54e-07 | 76 | 240 | 9 | IPR001664 | |
| Domain | IQ | 9.60e-07 | 81 | 240 | 9 | SM00015 | |
| Domain | Intermediate_filament_CS | 1.39e-06 | 63 | 240 | 8 | IPR018039 | |
| Domain | IQ_motif_EF-hand-BS | 2.35e-06 | 90 | 240 | 9 | IPR000048 | |
| Domain | IQ | 3.50e-06 | 71 | 240 | 8 | PF00612 | |
| Domain | Filament | 3.50e-06 | 71 | 240 | 8 | SM01391 | |
| Domain | Myosin_S1_N | 2.06e-05 | 5 | 240 | 3 | IPR008989 | |
| Domain | Dynein_HC_stalk | 2.41e-05 | 14 | 240 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.41e-05 | 14 | 240 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.41e-05 | 14 | 240 | 4 | PF08393 | |
| Domain | MT | 2.41e-05 | 14 | 240 | 4 | PF12777 | |
| Domain | IQ | 2.63e-05 | 93 | 240 | 8 | PS50096 | |
| Domain | DHC_fam | 3.25e-05 | 15 | 240 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.25e-05 | 15 | 240 | 4 | PF03028 | |
| Domain | Myosin_N | 3.25e-05 | 15 | 240 | 4 | PF02736 | |
| Domain | Dynein_heavy_dom | 3.25e-05 | 15 | 240 | 4 | IPR004273 | |
| Domain | Myosin_N | 3.25e-05 | 15 | 240 | 4 | IPR004009 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 DDX5 TRANK1 MDN1 KIF19 KIF5C KIF11 DHX16 DNHD1 SEPTIN4 YTHDC2 FANCM TEP1 DNAH7 DNAH1 PALS1 ABCG1 MYH14 IGHMBP2 SNRNP200 DNAH11 | 3.76e-05 | 848 | 240 | 26 | IPR027417 |
| Domain | Myosin_tail_1 | 7.06e-05 | 18 | 240 | 4 | PF01576 | |
| Domain | Myosin_tail | 7.06e-05 | 18 | 240 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 8.86e-05 | 19 | 240 | 4 | IPR027401 | |
| Domain | - | 8.86e-05 | 19 | 240 | 4 | 4.10.270.10 | |
| Domain | PH_dom-like | MYO10 TBC1D2 TBC1D2B RGPD1 OBSCN DGKH PTK2 RABGAP1L NSMAF DOCK10 ARHGEF12 TRIOBP CNKSR2 CIT ARHGEF1 SOS2 | 1.33e-04 | 426 | 240 | 16 | IPR011993 |
| Domain | DM14 | 1.64e-04 | 2 | 240 | 2 | SM00685 | |
| Domain | Acyl-CoA_ox_N | 1.64e-04 | 2 | 240 | 2 | PF14749 | |
| Domain | Acyl-CoA_ox_N | 1.64e-04 | 2 | 240 | 2 | IPR029320 | |
| Domain | DM14 | 1.64e-04 | 2 | 240 | 2 | IPR006608 | |
| Domain | Spectrin | 1.94e-04 | 23 | 240 | 4 | PF00435 | |
| Domain | TPR-like_helical_dom | RGPD1 TTC1 XAB2 TRANK1 P3H1 SMG6 RAPSN NAA15 POLR1A IFT122 PRKDC | 2.23e-04 | 233 | 240 | 11 | IPR011990 |
| Domain | PH | MYO10 TBC1D2 TBC1D2B OBSCN DGKH DOCK10 ARHGEF12 TRIOBP CNKSR2 CIT ARHGEF1 SOS2 | 2.67e-04 | 278 | 240 | 12 | SM00233 |
| Domain | F_BAR | 2.72e-04 | 25 | 240 | 4 | IPR031160 | |
| Domain | F_BAR | 2.72e-04 | 25 | 240 | 4 | PS51741 | |
| Domain | PH_DOMAIN | MYO10 TBC1D2 TBC1D2B OBSCN DGKH DOCK10 ARHGEF12 TRIOBP CNKSR2 CIT ARHGEF1 SOS2 | 2.75e-04 | 279 | 240 | 12 | PS50003 |
| Domain | PH_domain | MYO10 TBC1D2 TBC1D2B OBSCN DGKH DOCK10 ARHGEF12 TRIOBP CNKSR2 CIT ARHGEF1 SOS2 | 2.85e-04 | 280 | 240 | 12 | IPR001849 |
| Domain | - | 4.89e-04 | 3 | 240 | 2 | 3.40.50.10130 | |
| Domain | DNA_repair_nuc_XPF/helicase | 4.89e-04 | 3 | 240 | 2 | IPR020819 | |
| Domain | RGS-like_dom | 4.89e-04 | 3 | 240 | 2 | IPR015212 | |
| Domain | srGAP2 | 4.89e-04 | 3 | 240 | 2 | IPR030252 | |
| Domain | RGS-like | 4.89e-04 | 3 | 240 | 2 | PF09128 | |
| Domain | Spectrin_repeat | 4.91e-04 | 29 | 240 | 4 | IPR002017 | |
| Domain | Cadherin_CS | 5.20e-04 | 109 | 240 | 7 | IPR020894 | |
| Domain | - | MYO10 TBC1D2 TBC1D2B RGPD1 OBSCN DGKH RABGAP1L DOCK10 ARHGEF12 TRIOBP CNKSR2 CIT ARHGEF1 SOS2 | 5.62e-04 | 391 | 240 | 14 | 2.30.29.30 |
| Domain | CADHERIN_1 | 6.45e-04 | 113 | 240 | 7 | PS00232 | |
| Domain | Cadherin | 6.45e-04 | 113 | 240 | 7 | PF00028 | |
| Domain | - | 6.66e-04 | 148 | 240 | 8 | 2.60.40.150 | |
| Domain | CADHERIN_2 | 6.80e-04 | 114 | 240 | 7 | PS50268 | |
| Domain | - | 6.80e-04 | 114 | 240 | 7 | 2.60.40.60 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.87e-04 | 14 | 240 | 3 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 6.87e-04 | 14 | 240 | 3 | IPR011704 | |
| Domain | AAA_8 | 6.87e-04 | 14 | 240 | 3 | PF12780 | |
| Domain | AAA_5 | 6.87e-04 | 14 | 240 | 3 | PF07728 | |
| Domain | CA | 7.16e-04 | 115 | 240 | 7 | SM00112 | |
| Domain | SPEC | 7.21e-04 | 32 | 240 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.21e-04 | 32 | 240 | 4 | IPR018159 | |
| Domain | TPR-contain_dom | 7.27e-04 | 150 | 240 | 8 | IPR013026 | |
| Domain | Cadherin-like | 7.54e-04 | 116 | 240 | 7 | IPR015919 | |
| Domain | PH | MYO10 TBC1D2 TBC1D2B OBSCN DGKH DOCK10 TRIOBP CNKSR2 CIT SOS2 | 7.86e-04 | 229 | 240 | 10 | PF00169 |
| Domain | Cadherin | 8.34e-04 | 118 | 240 | 7 | IPR002126 | |
| Domain | KASH | 9.70e-04 | 4 | 240 | 2 | IPR012315 | |
| Domain | ACOX | 9.70e-04 | 4 | 240 | 2 | PF01756 | |
| Domain | KASH | 9.70e-04 | 4 | 240 | 2 | PS51049 | |
| Domain | KASH | 9.70e-04 | 4 | 240 | 2 | SM01249 | |
| Domain | Acyl-CoA_oxidase_C | 9.70e-04 | 4 | 240 | 2 | IPR002655 | |
| Domain | KASH | 9.70e-04 | 4 | 240 | 2 | PF10541 | |
| Domain | Phosphogly_mut1 | 9.70e-04 | 4 | 240 | 2 | IPR005952 | |
| Domain | Acyl-CoA_oxidase | 9.70e-04 | 4 | 240 | 2 | IPR012258 | |
| Domain | LRR | 1.20e-03 | 201 | 240 | 9 | PS51450 | |
| Domain | C2_dom | 1.30e-03 | 164 | 240 | 8 | IPR000008 | |
| Domain | TPR_REGION | 1.35e-03 | 165 | 240 | 8 | PS50293 | |
| Domain | TPR | 1.35e-03 | 165 | 240 | 8 | PS50005 | |
| Domain | LAM_G_DOMAIN | 1.39e-03 | 38 | 240 | 4 | PS50025 | |
| Domain | - | 1.47e-03 | 207 | 240 | 9 | 1.25.40.10 | |
| Domain | ARM-type_fold | RALGAPA1 STAG1 NEK10 USP9X NCDN AP3D1 FMNL1 MROH9 HEATR5A ARVCF PRKDC XPO7 | 1.52e-03 | 339 | 240 | 12 | IPR016024 |
| Domain | GDS_CDC24_CS | 1.54e-03 | 39 | 240 | 4 | IPR001331 | |
| Domain | Restrct_endonuc-II-like | 1.60e-03 | 5 | 240 | 2 | IPR011335 | |
| Domain | ERCC4 | 1.60e-03 | 5 | 240 | 2 | SM00891 | |
| Domain | ERCC4_domain | 1.60e-03 | 5 | 240 | 2 | IPR006166 | |
| Domain | ERCC4 | 1.60e-03 | 5 | 240 | 2 | PF02732 | |
| Domain | Laminin_G_2 | 1.69e-03 | 40 | 240 | 4 | PF02210 | |
| Domain | RhoGEF | 1.81e-03 | 68 | 240 | 5 | SM00325 | |
| Domain | RhoGEF | 2.06e-03 | 70 | 240 | 5 | PF00621 | |
| Domain | DH_2 | 2.06e-03 | 70 | 240 | 5 | PS50010 | |
| Domain | LRR_1 | 2.16e-03 | 219 | 240 | 9 | PF00560 | |
| Domain | - | 2.20e-03 | 71 | 240 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 2.20e-03 | 71 | 240 | 5 | IPR000219 | |
| Domain | GOLGA6L | 2.38e-03 | 6 | 240 | 2 | IPR026737 | |
| Domain | Dilute_dom | 2.38e-03 | 6 | 240 | 2 | IPR002710 | |
| Domain | DUF3398 | 2.38e-03 | 6 | 240 | 2 | PF11878 | |
| Domain | DIL | 2.38e-03 | 6 | 240 | 2 | PF01843 | |
| Domain | CPSASE_2 | 2.38e-03 | 6 | 240 | 2 | PS00867 | |
| Domain | DILUTE | 2.38e-03 | 6 | 240 | 2 | PS51126 | |
| Domain | DOCK_C/D_N | 2.38e-03 | 6 | 240 | 2 | IPR021816 | |
| Domain | DIL | 2.38e-03 | 6 | 240 | 2 | SM01132 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | RALGAPA1 FILIP1 USP9X SPTAN1 OBSCN GMIP FMNL1 PLXNB1 AMIGO2 DOCK10 ANKRD26 ARHGEF12 SRGAP2 CIT ARHGEF1 DOCK7 PKN1 PCDH7 SOS2 | 1.08e-05 | 450 | 190 | 19 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 FILIP1 MYH11 USP9X SPTAN1 RGPD1 OBSCN GMIP PTK2 FMNL1 PLXNB1 AMIGO2 NUP107 DOCK10 ANKRD26 ARHGEF12 SRGAP2 MYH14 ARHGEF1 DOCK7 PKN1 PCDH7 SOS2 | 2.15e-05 | 649 | 190 | 23 | MM15690 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.21e-05 | 87 | 190 | 8 | MM15351 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | RALGAPA1 FILIP1 USP9X SPTAN1 OBSCN GMIP FMNL1 PLXNB1 AMIGO2 DOCK10 ANKRD26 ARHGEF12 SRGAP2 ARHGEF1 DOCK7 PKN1 PCDH7 SOS2 | 2.76e-05 | 439 | 190 | 18 | MM15595 |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.23e-05 | 70 | 190 | 7 | M12294 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 7.85e-05 | 77 | 190 | 7 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.00e-04 | 80 | 190 | 7 | M800 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RALGAPA1 FILIP1 MYH11 USP9X SPTAN1 OBSCN GMIP PTK2 FMNL1 PLXNB1 AMIGO2 NUP107 DOCK10 ANKRD26 ARHGEF12 SRGAP2 CIT MYH14 ARHGEF1 DOCK7 PKN1 PCDH7 SOS2 | 1.06e-04 | 720 | 190 | 23 | M41838 |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.31e-04 | 20 | 190 | 4 | M18415 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.75e-04 | 24 | 190 | 4 | M2243 | |
| Pubmed | MYH2 MYH3 MYH11 STAG1 MYO5A MYO5B SPTAN1 RGPD1 SIK1 SSR2 PGAM1 DDX5 MDN1 SYNE2 KRT40 PGAM4 KRT20 NLE1 KIF5C ALDH1A1 ALDH2 EEA1 DMD AP3D1 KIF11 AMIGO2 PLXNA3 KRT2 KRT10 CUX2 KRT13 KRT15 KRT17 KRT34 SYNE1 PPFIA4 ANKRD26 CC2D1B SRBD1 CCDC77 NFE2L3 MYH14 IFT122 PRKDC ENO1 | 5.24e-17 | 1442 | 247 | 45 | 35575683 | |
| Pubmed | RALGAPA1 MYH11 MYO5A MYO5B USP9X SPTAN1 LRRC49 SPIRE1 PGAM1 GFAP NCDN DDX5 SLC12A5 NRXN2 PGAM4 UQCRC1 KIF5C ALDH2 DMD AP3D1 KRT2 KRT10 CAD NEDD4L SEPTIN4 SYNE1 PPFIA4 ARHGEF12 YTHDC2 CNKSR2 SRGAP2 APOE CIT ARVCF MYH14 CSNK2A1 ARHGEF1 KIAA1217 PDE4DIP DOCK7 LRRCC1 SNRNP200 DNAH11 | 1.09e-15 | 1431 | 247 | 43 | 37142655 | |
| Pubmed | MYO5A USP9X SPTAN1 RGPD1 TENM2 NCDN PTK2 SLC12A5 MDN1 SYNE2 KCNMA1 KIF5C MGA NOP2 KIF11 SMG6 CAD NEDD4L SYNE1 ARHGEF12 TRIOBP CNKSR2 SRGAP2 CIT SHISA7 PALS1 ARVCF CSNK2A1 KIAA1217 PDE4DIP DOCK7 PKN1 ENO1 | 9.19e-14 | 963 | 247 | 33 | 28671696 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A MYO5B USP9X NCDN XAB2 DDX5 MDN1 SYNE2 NLE1 NOL7 EEA1 MGA NOP2 DHX16 TBC1D15 CAD POLR1A NEDD4L KRT17 NUP107 SYNE1 BAZ1B YTHDC2 CIT TBL3 FAM83H MYH14 CSNK2A1 DOCK7 PRKDC ENO1 SNRNP200 XPO7 | 4.97e-13 | 1024 | 247 | 33 | 24711643 |
| Pubmed | MYO5A USP9X SPTAN1 PGAM1 XAB2 MDN1 SYNE2 NLE1 UQCRC1 NOP2 DHX16 CAD NAA15 POLR1A NUP107 NUP88 BAZ1B YTHDC2 TBL3 MYH14 CSNK2A1 DOCK7 PRKDC SNRNP200 XPO7 | 1.08e-11 | 653 | 247 | 25 | 22586326 | |
| Pubmed | DNAJB12 MYO5A USP9X ACOX1 HLA-F CC2D1A RETSAT PGAM1 NCDN XAB2 DDX5 MDN1 GLG1 P3H1 ADAM17 AP3D1 FMNL1 KIF11 KRT2 KRT10 CAD NAA15 NUP107 PIGK DOCK10 APOE CCDC77 CIT MYH14 IGHMBP2 IFT122 PRKDC ENO1 | 1.68e-11 | 1168 | 247 | 33 | 19946888 | |
| Pubmed | RALGAPA1 DNAJB12 MYO5A SPTAN1 MRPL19 CC2D1A TTC1 NCDN MDN1 GLG1 P3H1 SYNE2 ASCC2 NLE1 ALDH2 TMX3 NOP2 AP3D1 TBC1D15 KRT13 CAD NAA15 NUP107 SYNE1 DNAJC30 ANKRD26 SHMT1 TRIOBP BAZ1B CCDC77 TBL3 DARS2 MRPS14 IFT122 PCDH7 SNRNP200 NIN | 3.43e-11 | 1487 | 247 | 37 | 33957083 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | IMPDH1 MYO5A SPTAN1 HLA-F OBSCN PGAM1 GFAP KCNMA1 KRT20 ACAA2 EEA1 CPLANE1 KRT2 KRT10 KRT13 CAD KRT15 KRT17 FAM83H IFT122 PRKDC ENO1 | 1.39e-10 | 564 | 247 | 22 | 21565611 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 DNAJB12 MYO5A OBSCN SPIRE1 DGKH NCDN PTK2 KCNMA1 AFF1 KATNIP RPRD2 UQCRC1 KIF5C TMX3 NSMAF SMG6 POLR1A NEDD4L NRF1 LAMA3 TRIOBP SRGAP2 TEP1 HEXIM2 DNAH1 PTPDC1 ABCG1 MYH14 KIAA1217 CAMKMT PKN1 IFT122 ZRANB1 XPO7 SOS2 | 1.44e-10 | 1489 | 247 | 36 | 28611215 |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | MYH3 MYH11 SPTAN1 PGAM1 DDX5 BGN ADAM17 DMD NAA15 SYNE1 APOE MYH14 ENO1 SNRNP200 | 1.72e-10 | 197 | 247 | 14 | 29872149 |
| Pubmed | MYH11 SPTAN1 TTC1 GFAP PTK2 KRT20 DMD CPLANE1 MGA WDR44 KRT13 KRT15 NEDD4L KRT17 SYNE1 LAMA3 ARHGEF1 PRKDC SNRNP200 SOS2 | 3.94e-10 | 486 | 247 | 20 | 20936779 | |
| Pubmed | MYH11 USP9X SPTAN1 DDX5 CASS4 KRT2 KRT10 KRT13 CAD KRT15 KRT17 KRT34 MYH14 PRKDC SOS2 | 9.58e-10 | 266 | 247 | 15 | 19380743 | |
| Pubmed | MYO10 TENM2 NCDN SNX13 SLC12A5 RABGAP1L KATNIP DHX16 NEDD4L SYNE1 DOCK10 ARHGEF12 CNKSR2 HEATR5A FEM1B PDE4DIP DOCK7 XPO7 | 9.83e-10 | 407 | 247 | 18 | 12693553 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO5A MYO5B SPTAN1 XAB2 DDX5 ASCC2 NLE1 NOP2 KIF11 DHX16 KRT2 KRT10 KRT13 CAD NAA15 KRT15 KRT17 LAMA3 BAZ1B YTHDC2 SRBD1 CIT TBL3 FAM83H PALS1 CSNK2A1 KIAA1217 DOCK7 PRKDC ENO1 SNRNP200 | 1.95e-09 | 1257 | 247 | 31 | 36526897 |
| Pubmed | 4.31e-09 | 20 | 247 | 6 | 12743021 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A SPTAN1 MCCC1 PTK2 DDX5 MDN1 NLE1 ACAA2 UQCRC1 MGA NOP2 AP3D1 KIF11 DHX16 KRT2 CAD NAA15 POLR1A NUP107 DOCK10 BAZ1B CASP8 SRBD1 TBL3 FAM83H ARVCF MYH14 ARHGEF1 PRKDC ENO1 SNRNP200 | 1.08e-08 | 1353 | 247 | 31 | 29467282 |
| Pubmed | MYH11 MYO10 SPTAN1 TBC1D2 MCCC1 NUP88 TRIOBP CIT KIAA1217 DOCK7 | 1.35e-08 | 118 | 247 | 10 | 30979931 | |
| Pubmed | 1.60e-08 | 63 | 247 | 8 | 16831889 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH11 MYO5A AP3D1 KRT2 KRT10 CAD NUP107 CIT MYH14 DOCK7 PRKDC SNRNP200 | 2.65e-08 | 202 | 247 | 12 | 33005030 |
| Pubmed | 4.92e-08 | 15 | 247 | 5 | 10087197 | ||
| Pubmed | USP9X SPTAN1 MCCC1 DDX5 NOL7 DMD AP3D1 KRT2 KRT10 KRT13 KRT17 KRT34 LAMA3 TRIOBP MYH14 PRKDC ENO1 | 9.47e-08 | 488 | 247 | 17 | 31324722 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DNAJB12 USP9X SPTAN1 RBM26 CC2D1A NCDN XAB2 DDX5 GLG1 SYNE2 NOP2 AP3D1 KIF11 KRT2 KRT10 KRT13 CAD NAA15 KRT15 NEDD4L KRT17 KRT34 SRGAP2 DARS2 CSNK2A1 ARHGEF1 MRPS14 PRKDC ENO1 SNRNP200 | 1.04e-07 | 1415 | 247 | 30 | 28515276 |
| Pubmed | DNAJB12 IMPDH1 MYO5A RBM26 SPIRE1 XAB2 DMAP1 MDN1 GLG1 ASCC2 FAM83D NOL7 UQCRC1 SMG6 INO80E CAD POLR1A PIGK SYNE1 ARHGEF12 TRIOBP BAZ1B YTHDC2 SRGAP2 SRBD1 PNKD CIT TBL3 CSNK2A1 IGHMBP2 MRPS14 | 1.05e-07 | 1497 | 247 | 31 | 31527615 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP9X SPTAN1 RBM26 PGAM1 DDX5 MDN1 NOL7 UQCRC1 ALDH2 EEA1 NOP2 KIF11 DHX16 DNHD1 TBC1D15 CAD POLR1A NUP107 SYNE1 NUP88 BAZ1B YTHDC2 TBL3 DARS2 MYH14 CSNK2A1 DOCK7 PRKDC ENO1 SNRNP200 | 1.21e-07 | 1425 | 247 | 30 | 30948266 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MYO10 USP9X RBM26 TBC1D2B SIK1 CC2D1A HAUS3 GMIP TTC1 NCDN DDX5 WWC2 KATNIP RPRD2 DMD AP3D1 DHX16 TBC1D15 NEDD4L HEXIM2 PTPDC1 CSNK2A1 ARHGEF1 KIAA1217 DOCK7 | 1.25e-07 | 1038 | 247 | 25 | 26673895 |
| Pubmed | DNAJB12 RBM26 MCCC1 NCDN XAB2 DMAP1 GLG1 ASCC2 ACAA2 UQCRC1 ALDH2 TMX3 KIF11 TBC1D15 NUP107 NUP88 TBL3 SNRNP200 | 1.30e-07 | 560 | 247 | 18 | 35241646 | |
| Pubmed | MYH3 NEK10 GFAP SNX13 KIF11 KRT2 KRT10 KRT17 KRT34 PDE4DIP ENO1 | 1.90e-07 | 197 | 247 | 11 | 23686814 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH11 GIN1 USP9X SPTAN1 HAUS3 GOLPH3 PGAM1 DDX5 MDN1 RABGAP1L KIF5C EEA1 AP3D1 NAA15 POLR1A CIT MYH14 KIAA1217 MRPS14 PRKDC ENO1 SNRNP200 | 2.09e-07 | 847 | 247 | 22 | 35235311 |
| Pubmed | CC2D1A MCCC1 FAT1 MGA NOP2 AP3D1 KRT2 FAT4 KRT10 KRT17 NUP107 ANKRD26 CNKSR2 DNAH7 VIPAS39 DOCK7 PKN1 PRKDC PCDH7 SNRNP200 XPO7 | 2.09e-07 | 777 | 247 | 21 | 35844135 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB12 MYH2 MYH3 MYH11 SPTAN1 HLA-F RGPD1 PGAM1 MDN1 PGAM4 ADAM17 UQCRC1 TBC1D15 CAD CCDC80 KLHL22 MYH14 PRKDC ENO1 | 2.32e-07 | 647 | 247 | 19 | 26618866 |
| Pubmed | MYH11 PTK2 NOP2 KRT2 CAD POLR1A TBL3 MYH14 DOCK7 PRKDC SNRNP200 | 2.45e-07 | 202 | 247 | 11 | 24639526 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 MYO10 P3H1 TMX3 KIF11 INO80E POLR1A NEDD4L KRT17 KRT34 NUP88 YTHDC2 CNKSR2 SRBD1 TBL3 KLHL22 FEM1B PALS1 CSNK2A1 MRPS14 DOCK7 SNRNP200 ZRANB1 NIN | 2.64e-07 | 1005 | 247 | 24 | 19615732 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 SPTAN1 SPIRE1 SIK1 CC2D1A MCCC1 WWC2 MDN1 RABGAP1L SYNE2 KIF5C KIF11 NAA15 NEDD4L ANKRD26 SRGAP2 DNAH7 FAM83H ARHGEF1 KIAA1217 DOCK7 PCDH7 | 2.76e-07 | 861 | 247 | 22 | 36931259 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO5A SPTAN1 CC2D1A HAUS3 MCCC1 PGAM1 PTK2 XAB2 ASCC2 FAM83D MGA NOP2 INO80E POLR1A ANKRD26 TRIOBP YTHDC2 SRGAP2 MYH14 DOCK7 | 2.92e-07 | 724 | 247 | 20 | 36232890 |
| Pubmed | MYO5A SPTAN1 DDX5 P3H1 KIF5C NOP2 CAD POLR1A NUP107 NUP88 BAZ1B SRGAP2 CIT TBL3 CSNK2A1 DOCK7 PRKDC NHEJ1 SNRNP200 | 3.14e-07 | 660 | 247 | 19 | 32780723 | |
| Pubmed | SPTAN1 CC2D1A MCCC1 ACAA2 EEA1 DHX16 KRT15 NUP107 TRIOBP SRGAP2 DARS2 ARHGEF1 KIAA1217 PRKDC | 3.56e-07 | 360 | 247 | 14 | 33111431 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | IMPDH1 MYO10 OBSCN SPIRE1 CC2D1A FANCA FAT1 MDN1 NLE1 AP3D1 SMG6 SEMA3F PLXNA3 FAM89A NRF1 MUS81 SRGAP2 TEP1 CIT FAM83H ARVCF KLHL36 PKN1 PRKDC BCAM | 3.99e-07 | 1105 | 247 | 25 | 35748872 |
| Pubmed | MYO5A USP9X SPTAN1 LRRC49 RGPD1 CC2D1A MCCC1 DMAP1 TLX2 FAT1 SYNE2 RPRD2 UQCRC1 MGA NOP2 INO80E CAD NUP107 NUP88 BAZ1B E2F1 CIT HEXIM2 ZNF284 PALS1 MYH14 CSNK2A1 MRPS14 PCDH7 | 4.24e-07 | 1429 | 247 | 29 | 35140242 | |
| Pubmed | USP9X SPTAN1 RBM26 CC2D1A DMAP1 RPRD2 MGA WDR44 TBC1D15 CAD BAZ1B APOE PALS1 DOCK7 PRKDC ENO1 SNRNP200 | 4.93e-07 | 549 | 247 | 17 | 38280479 | |
| Pubmed | STAG1 MYO5A USP9X SPTAN1 ZNF224 ZNF227 GFAP PTK2 XAB2 DMAP1 UQCRC1 KIF5C SPATC1L CIB1 SYNE1 TRIOBP SRGAP2 APOE CIT NFE2L3 MYH14 PDE4DIP LRRCC1 IFT122 PRKDC SNRNP200 SOS2 | 5.64e-07 | 1285 | 247 | 27 | 35914814 | |
| Pubmed | STAG1 MYO5B SPTAN1 DDX5 MDN1 MGA NOP2 CAD NUP107 PRKDC ENO1 SNRNP200 | 6.63e-07 | 272 | 247 | 12 | 31010829 | |
| Pubmed | DNAJB12 SPTAN1 RETSAT XAB2 DDX5 DMAP1 FAT1 GLG1 P3H1 SYNE2 NLE1 UQCRC1 EEA1 TMX3 AP3D1 KIF11 DHX16 KRT2 TBC1D15 CAD NEDD4L PIGK TBL3 DARS2 CSNK2A1 ARHGEF1 PRKDC | 6.74e-07 | 1297 | 247 | 27 | 33545068 | |
| Pubmed | NRXN2 SYNE2 RPRD2 SMG6 CUX2 SYNE1 DOCK10 TRIOBP SNRNP200 UNC80 NIN | 7.14e-07 | 225 | 247 | 11 | 12168954 | |
| Pubmed | 8.27e-07 | 104 | 247 | 8 | 36055981 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | RALGAPA1 MYO5A USP9X SPTAN1 NCDN PTK2 SYNE1 CNKSR2 SRGAP2 CIT SHISA7 PCDH7 | 9.34e-07 | 281 | 247 | 12 | 28706196 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RGPD1 CC2D1A HAUS3 MCCC1 TTC1 PGAM1 NCDN KIF5C CPLANE1 MGA RNF135 NUP88 ANKRD26 CASP8 CCDC77 DNAH7 FAM83H KLHL22 KIAA1217 LRRCC1 NIN | 9.43e-07 | 853 | 247 | 21 | 28718761 |
| Pubmed | OBSCN SPIRE1 UNC13D NCDN WWC2 FMN1 GLG1 AFF1 ADAM17 TMX3 CPLANE1 MGA PCDH18 PLXNB1 KIF11 FAM234B SPOPL SHMT1 BAZ1B SRGAP2 CCDC77 FEM1B ARHGEF1 CCDC171 | 1.01e-06 | 1084 | 247 | 24 | 11544199 | |
| Pubmed | SPTAN1 SYNE2 DMD KIF11 DNHD1 KRT10 SYNE1 ARHGEF12 MYH14 ARHGEF1 | 1.02e-06 | 187 | 247 | 10 | 26460568 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBM26 CC2D1A MCCC1 TTC1 XAB2 DDX5 RPRD2 NOP2 AP3D1 KIF11 WDR44 NAA15 NUP107 NUP88 ANKRD26 BAZ1B YTHDC2 SRGAP2 KIAA1217 PRKDC ENO1 SNRNP200 | 1.07e-06 | 934 | 247 | 22 | 33916271 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH3 MYO5B CC2D1A DDX5 BGN FAT1 GLG1 P3H1 ALDH1A1 ALDH2 EEA1 DNHD1 CUX2 CIB1 NRF1 ARHGEF12 SHMT1 CNKSR2 APOE PALS1 CD14 MYH14 BCAM | 1.18e-06 | 1016 | 247 | 23 | 19056867 |
| Pubmed | 1.21e-06 | 76 | 247 | 7 | 27542412 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | STAG1 USP9X IKZF1 XAB2 MDN1 SYNE2 NOP2 CAD GCFC2 BAZ1B CSNK2A1 PRKDC | 1.25e-06 | 289 | 247 | 12 | 23752268 |
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 23512986 | ||
| Pubmed | MYO5A SPTAN1 DDX5 NOL7 ALDH1A1 NOP2 KRT2 KRT10 NUP107 MYH14 MRPS14 PRKDC | 1.55e-06 | 295 | 247 | 12 | 26209609 | |
| Pubmed | GMIP DMAP1 FAT4 TBC1D15 GCFC2 ARHGEF12 CNKSR2 VIPAS39 ARVCF CSNK2A1 PKN1 | 1.71e-06 | 246 | 247 | 11 | 15345747 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 USP9X SPTAN1 PTK2 DDX5 FMN1 KCNMA1 NOP2 AP3D1 FMNL1 NAA15 ARHGEF12 YTHDC2 SHISA7 ENO1 | 1.85e-06 | 475 | 247 | 15 | 31040226 |
| Pubmed | Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set. | 2.02e-06 | 157 | 247 | 9 | 12466305 | |
| Pubmed | 2.34e-06 | 54 | 247 | 6 | 35474131 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH11 MYO5A MYO5B SPTAN1 MCCC1 GFAP TLR8 PTK2 DDX5 SLC12A5 UQCRC1 KIF5C ALDH1A1 ALDH2 SEPTIN4 CSNK2A1 ENO1 | 2.63e-06 | 621 | 247 | 17 | 22794259 |
| Pubmed | MYH11 USP9X MRPL19 GFAP DDX5 RABGAP1L KRT20 AFF1 KIF5C KRT2 KRT10 KRT13 CAD KRT15 KRT17 YTHDC2 DNAH7 HEXIM2 MYH14 CSNK2A1 MRPS14 PRKDC ENO1 SNRNP200 | 2.92e-06 | 1153 | 247 | 24 | 29845934 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | USP9X RBM26 TBC1D2B OBSCN TRANK1 MDN1 KIF19 ASCC2 AP3D1 POLR1A YTHDC2 APOE CSNK2A1 IGHMBP2 CSNK2A3 | 3.21e-06 | 497 | 247 | 15 | 36774506 |
| Pubmed | 3.24e-06 | 57 | 247 | 6 | 31862882 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 SPTAN1 TBC1D2 ZNF224 WWC2 MDN1 AFF1 NOP2 WDR44 DHX16 GCFC2 BAZ1B YTHDC2 HEXIM2 CSNK2A1 PKN1 PRKDC PCDH7 SNRNP200 | 3.29e-06 | 774 | 247 | 19 | 15302935 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | STAG1 DDX5 NLE1 ACAA2 UQCRC1 KIF5C AP3D1 KIF11 DHX16 CAD POLR1A PIGK NUP88 BAZ1B YTHDC2 DARS2 PRKDC SNRNP200 | 3.44e-06 | 704 | 247 | 18 | 29955894 |
| Pubmed | 3.70e-06 | 169 | 247 | 9 | 31462741 | ||
| Pubmed | RALGAPA1 DNAJB12 USP9X CC2D1A PGAM1 DDX5 AP3D1 TBC1D15 CAD ANKRD26 ARHGEF12 CC2D1B YTHDC2 DOCK7 PRKDC ENO1 PCDH7 SNRNP200 | 3.72e-06 | 708 | 247 | 18 | 39231216 | |
| Pubmed | DNAJB12 USP9X SPTAN1 DDX5 MDN1 NOP2 AP3D1 KIF11 TBC1D15 CAD NAA15 NUP107 TBL3 FAM83H PRKDC CSNK2A3 SNRNP200 | 3.76e-06 | 638 | 247 | 17 | 33239621 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | MYH11 USP9X MCCC1 NOP2 CAD NAA15 NUP107 TBL3 MYH14 PRKDC SNRNP200 | 4.49e-06 | 272 | 247 | 11 | 25315684 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH11 MYO5A MYO5B MYO10 SPTAN1 PGAM1 DDX5 ACAA2 NOP2 KRT2 KRT10 CAD KRT17 MYH14 DOCK7 ENO1 | 4.72e-06 | 580 | 247 | 16 | 35676659 |
| Pubmed | GMIP NCDN PTK2 XAB2 FANCA AP3D1 PLXNB1 DHX16 NAA15 DOCK10 CC2D1B YTHDC2 PALS1 ARVCF ARHGEF1 DOCK7 IFT122 | 4.80e-06 | 650 | 247 | 17 | 38777146 | |
| Pubmed | STAG1 SPTAN1 XAB2 DDX5 FANCA UQCRC1 ALDH2 NOP2 KRT2 KRT17 MAFK BAZ1B FANCM MYH14 PRKDC ENO1 SNRNP200 | 5.00e-06 | 652 | 247 | 17 | 31180492 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 SPTAN1 MCCC1 PGAM1 DDX5 MDN1 GLG1 UQCRC1 ALDH1A1 EEA1 AP3D1 KRT10 CAD SYNE1 DNAH1 MYH14 PRKDC ENO1 SNRNP200 | 5.97e-06 | 807 | 247 | 19 | 30575818 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBM26 XAB2 DDX5 RPRD2 MGA NOP2 DHX16 BAZ1B YTHDC2 PRKDC SNRNP200 | 6.54e-06 | 283 | 247 | 11 | 30585729 |
| Pubmed | ACOX1 IKZF1 MDN1 RPRD2 NOP2 KRT2 KRT10 NUP107 BAZ1B TBL3 PRKDC SNRNP200 | 6.64e-06 | 340 | 247 | 12 | 29478914 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | SPTAN1 NLE1 MAP3K15 KIF5C SMG6 MYH14 CSNK2A1 PRKDC CSNK2A3 SNRNP200 | 6.76e-06 | 231 | 247 | 10 | 36597993 |
| Pubmed | RALGAPA1 MYO5A MYO5B USP9X SPTAN1 WWC2 P3H1 SYNE2 KCNMA1 DMD KRT2 CAD KRT17 NUP107 TRIOBP CCDC77 PTPDC1 VIPAS39 ARVCF CSNK2A1 PCDH7 NIN | 6.85e-06 | 1049 | 247 | 22 | 27880917 | |
| Pubmed | Developmental regulation of biglycan expression in muscle and tendon. | 6.97e-06 | 6 | 247 | 3 | 16810681 | |
| Pubmed | 7.03e-06 | 65 | 247 | 6 | 29795372 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | MYOC C3orf38 IKZF1 MCCC1 TTC1 GFAP PTK2 KRT40 DMD PHF21B CCDC33 KRT13 RAPSN KRT15 NRF1 APOE VIPAS39 PDE4DIP | 7.06e-06 | 742 | 247 | 18 | 26871637 |
| Pubmed | 7.57e-06 | 234 | 247 | 10 | 36243803 | ||
| Pubmed | MYO5A USP9X SPTAN1 RGPD1 MCCC1 TENM2 GFAP GLG1 RABGAP1L CAD NAA15 NEDD4L NUP88 TRIOBP CNKSR2 CIT SHISA7 VIPAS39 KIAA1217 IGHMBP2 PDE4DIP DOCK7 ENO1 | 7.75e-06 | 1139 | 247 | 23 | 36417873 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MYH3 DMAP1 FAM83D MGA KRT15 NRF1 DOCK10 TBL3 MYH14 ARHGEF1 MRPS14 DOCK7 SNRNP200 | 8.69e-06 | 410 | 247 | 13 | 26949251 |
| Pubmed | SPTAN1 CC2D1A DDX5 DMAP1 SYNE2 DMD MGA NOP2 SEMA3F FAT4 TBC1D15 CAD NUP107 SYNE1 NUP88 BAZ1B SNRNP200 ZRANB1 | 8.76e-06 | 754 | 247 | 18 | 35906200 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO5A USP9X SPTAN1 RBM26 TTC1 PGAM1 DDX5 MDN1 EEA1 AP3D1 KIF11 KRT2 KRT10 CAD NAA15 SHMT1 SRGAP2 PALS1 CSNK2A1 DOCK7 PRKDC ENO1 SNRNP200 | 8.92e-06 | 1149 | 247 | 23 | 35446349 |
| Pubmed | 9.47e-06 | 144 | 247 | 8 | 35681168 | ||
| Pubmed | ACOX1 HAUS3 RETSAT DDX5 MDN1 GLG1 P3H1 ASCC2 ACAA2 ALDH2 TMX3 TBC1D15 CAD SHMT1 DARS2 PALS1 ARHGEF1 | 9.69e-06 | 686 | 247 | 17 | 28380382 | |
| Pubmed | 9.97e-06 | 191 | 247 | 9 | 33762435 | ||
| Pubmed | IMPDH1 RBM26 MRPL19 XKR7 FAT1 MDN1 NLE1 RPRD2 TMX3 MGA TBC1D15 GCFC2 SRGAP2 CCDC77 PDE4DIP ENO1 DNAH11 | 1.02e-05 | 689 | 247 | 17 | 36543142 | |
| Pubmed | MYH11 IMPDH1 MYO5A SPTAN1 PGAM1 DDX5 SLC12A5 PGAM4 UQCRC1 ALDH1A1 DMD VIPAS39 MYH14 CSNK2A1 ENO1 | 1.12e-05 | 552 | 247 | 15 | 36293380 | |
| Pubmed | 1.12e-05 | 106 | 247 | 7 | 19394292 | ||
| Pubmed | IMPDH1 LRRC49 PTK2 XAB2 NRXN2 GLG1 RABGAP1L NOL7 KATNIP KIF5C IP6K2 IMPG2 SEMA3F SEPTIN4 FEM1B VIPAS39 CSNK2A1 PDE4DIP PRKDC ENO1 ZRANB1 | 1.20e-05 | 1006 | 247 | 21 | 15226823 | |
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 16818453 | ||
| Pubmed | Maternal aldehyde elimination during pregnancy preserves the fetal genome. | 1.21e-05 | 7 | 247 | 3 | 25155611 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | SPTAN1 DDX5 MGA NOP2 KIF11 KRT2 KRT10 KRT13 CAD KRT17 KRT34 DOCK10 CIT PDE4DIP PRKDC | 1.27e-05 | 558 | 247 | 15 | 27591049 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.28e-05 | 197 | 247 | 9 | 20811636 | |
| Pubmed | MYH2 MYO5A SPTAN1 PGAM1 KRT2 KRT10 FAM83H MYH14 DOCK7 PRKDC ENO1 | 1.32e-05 | 305 | 247 | 11 | 33194618 | |
| Pubmed | MYH3 OBSCN LRRC2 SYNE2 ACAA2 MGA TRIM38 KRT10 KRT17 SYNE1 ANKRD26 MYH14 PDE4DIP ENO1 | 1.48e-05 | 497 | 247 | 14 | 23414517 | |
| Pubmed | MYH2 GOLGA6L2 USP9X RGPD1 ZNF227 DCUN1D4 MDN1 SYNE2 NOL7 FAT4 PIGK DNAH7 TBL3 ARVCF MRPS14 DNAH11 | 1.54e-05 | 638 | 247 | 16 | 31182584 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | USP9X SPTAN1 HAUS3 DGKH DDX5 FAT1 NOP2 CCDC33 CAD LAMA3 SRGAP2 CSNK2A1 MRPS14 DOCK7 PRKDC SNRNP200 | 1.57e-05 | 639 | 247 | 16 | 23443559 |
| Pubmed | SPTAN1 GFAP DDX5 NOL7 KIF5C NOP2 AP3D1 DHX16 KRT2 KRT10 CAD KRT17 BAZ1B PRKDC ENO1 SNRNP200 | 1.63e-05 | 641 | 247 | 16 | 36057605 | |
| Interaction | KRT8 interactions | USP9X LRRC49 TBC1D2B HAUS3 GFAP KRT40 KRT20 DMD KRT2 KRT10 KRT13 CAD KRT15 KRT17 NUP107 KRT34 NUP88 ANKRD26 ARHGEF12 CCDC77 FAM83H DOCK7 PCDH7 ZRANB1 NIN | 1.58e-10 | 441 | 243 | 25 | int:KRT8 |
| Interaction | NEFL interactions | MYO5A SPTAN1 GMIP GFAP KCNMA1 CCDC33 KRT13 KRT15 CNKSR2 CIT FAM83H PDE4DIP PKN1 | 8.13e-08 | 161 | 243 | 13 | int:NEFL |
| Interaction | KCTD13 interactions | RALGAPA1 MYH11 MYO5A MYO5B USP9X SPTAN1 LRRC49 SPIRE1 PGAM1 GFAP NCDN DDX5 SLC12A5 NRXN2 UQCRC1 KIF5C ALDH2 DMD AP3D1 KRT2 KRT10 CAD NEDD4L SEPTIN4 SYNE1 PPFIA4 ARHGEF12 YTHDC2 CNKSR2 SRGAP2 APOE CIT ARVCF MYH14 CSNK2A1 ARHGEF1 KIAA1217 DOCK7 LRRCC1 SNRNP200 DNAH11 | 9.34e-08 | 1394 | 243 | 41 | int:KCTD13 |
| Interaction | DES interactions | SPTAN1 GFAP KRT20 KRT2 KRT10 KRT13 KRT15 KRT17 NUP88 CIT KLHL22 ENO1 | 5.02e-07 | 158 | 243 | 12 | int:DES |
| Interaction | AGRN interactions | MYH3 MYH11 SPTAN1 PGAM1 DDX5 BGN ADAM17 DMD NAA15 SYNE1 APOE MYH14 ENO1 SNRNP200 NIN | 9.31e-07 | 267 | 243 | 15 | int:AGRN |
| Interaction | NPHP4 interactions | IMPDH1 MYO5A SPTAN1 OBSCN GFAP KRT20 ACAA2 CPLANE1 KRT2 KRT10 KRT13 KRT15 KRT17 PRKDC | 1.14e-06 | 236 | 243 | 14 | int:NPHP4 |
| Interaction | SIRT7 interactions | MYO5A USP9X SPTAN1 PGAM1 XAB2 MDN1 SYNE2 NLE1 UQCRC1 NOP2 DHX16 CAD NAA15 POLR1A NUP107 NUP88 BAZ1B YTHDC2 TBL3 MYH14 CSNK2A1 DOCK7 PRKDC SNRNP200 ZRANB1 XPO7 | 1.23e-06 | 744 | 243 | 26 | int:SIRT7 |
| Interaction | DLGAP1 interactions | MYO5A USP9X SPTAN1 NCDN PTK2 KIF5C NEDD4L SYNE1 CNKSR2 CIT ARVCF KIAA1217 | 2.00e-06 | 180 | 243 | 12 | int:DLGAP1 |
| Interaction | KRT18 interactions | LRRC49 HAUS3 GFAP KRT20 KRT2 KRT10 CAD KRT15 KRT17 ANKRD26 CASP8 CCDC77 FAM83H KIAA1217 PDE4DIP PCDH7 ZRANB1 NIN | 3.63e-06 | 419 | 243 | 18 | int:KRT18 |
| Interaction | TNIK interactions | MYO5A USP9X SPTAN1 SYNE2 KCNMA1 KIF5C MGA CAD NEDD4L SYNE1 CNKSR2 CIT SHISA7 PALS1 KIAA1217 PDE4DIP DOCK7 | 4.13e-06 | 381 | 243 | 17 | int:TNIK |
| Interaction | MOS interactions | 4.51e-06 | 78 | 243 | 8 | int:MOS | |
| Interaction | KRT74 interactions | 4.91e-06 | 37 | 243 | 6 | int:KRT74 | |
| Interaction | CCDC8 interactions | MYO5A MYO5B USP9X NCDN DDX5 MDN1 EEA1 NOP2 TBC1D15 CAD POLR1A NEDD4L BAZ1B YTHDC2 FAM83H MYH14 CSNK2A1 DOCK7 PRKDC ENO1 SNRNP200 ZRANB1 XPO7 | 4.98e-06 | 656 | 243 | 23 | int:CCDC8 |
| Interaction | ATOH1 interactions | 5.46e-06 | 80 | 243 | 8 | int:ATOH1 | |
| Interaction | IFI16 interactions | SPTAN1 OBSCN PGAM1 XAB2 DDX5 RABGAP1L NLE1 NOP2 KIF11 DHX16 NUP107 SYNE1 NUP88 BAZ1B YTHDC2 SRBD1 CIT TBL3 MYH14 CSNK2A1 IGHMBP2 DOCK7 CSNK2A3 ENO1 | 6.27e-06 | 714 | 243 | 24 | int:IFI16 |
| Interaction | LATS1 interactions | MYH2 MYH3 USP9X SPTAN1 RGPD1 WWC2 MDN1 MGA NOP2 KIF11 CAD KRT17 ANKRD26 CCDC77 PALS1 MYH14 KIAA1217 NIN | 7.13e-06 | 440 | 243 | 18 | int:LATS1 |
| Interaction | LRRC31 interactions | MYH11 MYO5A AP3D1 KRT2 KRT10 CAD NUP107 CIT MYH14 DOCK7 PRKDC SNRNP200 | 7.67e-06 | 205 | 243 | 12 | int:LRRC31 |
| Interaction | PFN1 interactions | MYO5A SPTAN1 TBC1D2B PGAM1 RABGAP1L SYNE2 ACAA2 FMNL1 KIF11 WDR44 KRT17 ANKRD26 ARHGEF12 SRGAP2 ARHGEF1 KIAA1217 DOCK7 ENO1 ZRANB1 | 1.44e-05 | 509 | 243 | 19 | int:PFN1 |
| Interaction | HDAC11 interactions | 1.82e-05 | 154 | 243 | 10 | int:HDAC11 | |
| Interaction | CFTR interactions | DNAJB12 MYH2 MYH3 MYH11 USP9X SPTAN1 HLA-F RGPD1 MCCC1 ZNF112 PGAM1 DDX5 MDN1 PGAM4 NOL7 ADAM17 UQCRC1 KIF5C EEA1 DMD AP3D1 KRT2 TBC1D15 KRT10 KRT13 CAD KRT17 KRT34 DOCK10 LAMA3 TRIOBP CCDC80 DARS2 KLHL22 MYH14 PRKDC ENO1 | 1.85e-05 | 1480 | 243 | 37 | int:CFTR |
| Interaction | KCTD9 interactions | PGAM1 DDX5 KRT40 CCDC33 KRT2 KRT10 CAD KRT34 PNKD PRKDC ENO1 SNRNP200 | 1.95e-05 | 225 | 243 | 12 | int:KCTD9 |
| Interaction | STRIP1 interactions | 2.28e-05 | 97 | 243 | 8 | int:STRIP1 | |
| Interaction | KDM1A interactions | USP9X LRRC49 HAUS3 IKZF1 MCCC1 TTC1 RABGAP1L KRT40 ASCC2 MGA PHF21B KIF11 CCDC33 TBC1D15 KRT15 KRT17 NUP107 RNF135 NUP88 E2F1 CIT CSNK2A1 KIAA1217 PDE4DIP DOCK7 ZRANB1 NIN | 2.81e-05 | 941 | 243 | 27 | int:KDM1A |
| Interaction | TXLNA interactions | HAUS3 DMAP1 KRT40 KRT20 CCDC33 KRT13 KRT15 KRT34 RNF135 ARHGEF12 ZRANB1 NIN | 3.13e-05 | 236 | 243 | 12 | int:TXLNA |
| Interaction | PRPH interactions | MYO5A GFAP KCNMA1 KRT20 KRT2 KRT10 KRT15 KRT17 CIT KIAA1217 ENO1 | 3.93e-05 | 204 | 243 | 11 | int:PRPH |
| Interaction | KRT19 interactions | GFAP DMD KRT2 KRT10 KRT15 KRT17 NUP88 ANKRD26 CCDC77 FAM83H PKN1 ZRANB1 NIN | 4.08e-05 | 282 | 243 | 13 | int:KRT19 |
| Interaction | KRT81 interactions | 4.13e-05 | 53 | 243 | 6 | int:KRT81 | |
| Interaction | VIM interactions | MYOC SPTAN1 SIK1 CC2D1A UBE2U GFAP KCNMA1 KRT20 KRT2 KRT10 CAD GCFC2 KRT15 KRT17 DOCK10 TRIOBP CASP8 CNKSR2 CIT FAM83H KIAA1217 PKN1 PRKDC PCDH7 | 4.33e-05 | 804 | 243 | 24 | int:VIM |
| Interaction | LURAP1 interactions | 4.36e-05 | 137 | 243 | 9 | int:LURAP1 | |
| Interaction | MKS1 interactions | 4.89e-05 | 139 | 243 | 9 | int:MKS1 | |
| Interaction | KRT7 interactions | 5.11e-05 | 80 | 243 | 7 | int:KRT7 | |
| Interaction | CCDC40 interactions | 5.12e-05 | 34 | 243 | 5 | int:CCDC40 | |
| Interaction | CYLD interactions | SPTAN1 CC2D1A PTK2 DDX5 GLG1 EEA1 MGA NOP2 KIF11 KRT2 KRT10 KRT13 CAD KRT17 KRT34 CECR2 DOCK10 ARHGEF12 CASP8 CIT KLHL22 PDE4DIP PRKDC ENO1 NIN | 5.32e-05 | 868 | 243 | 25 | int:CYLD |
| Interaction | PPP1R18 interactions | 5.46e-05 | 141 | 243 | 9 | int:PPP1R18 | |
| Interaction | GAN interactions | SPTAN1 GFAP SYNE2 DMD KIF11 DNHD1 KRT10 KRT17 SYNE1 ARHGEF12 MYH14 ARHGEF1 | 6.14e-05 | 253 | 243 | 12 | int:GAN |
| Interaction | MIB1 interactions | FILIP1 USP9X LRRC49 HAUS3 UBE2U ASCC2 MGA TBC1D15 ANKRD26 YTHDC2 CCDC77 LRRCC1 NIN | 6.47e-05 | 295 | 243 | 13 | int:MIB1 |
| Interaction | CEP63 interactions | RALGAPA1 SPTAN1 LRRC49 RGPD1 HAUS3 KRT40 TBC1D15 SYNE1 CCDC77 NIN | 6.57e-05 | 179 | 243 | 10 | int:CEP63 |
| Interaction | C9orf78 interactions | DNAJB12 RBM26 MCCC1 NCDN XAB2 DMAP1 GLG1 ASCC2 ACAA2 UQCRC1 ALDH2 TMX3 KIF11 TBC1D15 NUP107 NUP88 TBL3 ENO1 SNRNP200 ZRANB1 | 6.76e-05 | 620 | 243 | 20 | int:C9orf78 |
| Interaction | KRT75 interactions | 7.21e-05 | 181 | 243 | 10 | int:KRT75 | |
| Interaction | KRT72 interactions | 7.63e-05 | 59 | 243 | 6 | int:KRT72 | |
| Interaction | KRT79 interactions | 7.63e-05 | 59 | 243 | 6 | int:KRT79 | |
| Interaction | SOHLH1 interactions | 7.77e-05 | 115 | 243 | 8 | int:SOHLH1 | |
| Interaction | PCM1 interactions | FILIP1 USP9X LRRC49 CC2D1A HAUS3 EEA1 KRT2 KRT15 ANKRD26 TRIOBP SRGAP2 CCDC77 KIAA1217 LRRCC1 ZRANB1 NIN | 8.02e-05 | 434 | 243 | 16 | int:PCM1 |
| Interaction | RHOB interactions | RALGAPA1 USP9X SPTAN1 TBC1D2B CC2D1A DGKH TENM2 PCDH17 FAT1 MDN1 FMNL1 WDR44 FAT4 NEDD4L ANKRD26 ARHGEF12 TRIOBP CIT PALS1 ARVCF ARHGEF1 DOCK7 PKN1 PCDH7 | 8.55e-05 | 840 | 243 | 24 | int:RHOB |
| Interaction | LGR4 interactions | MYH11 RETSAT NOP2 KRT2 CAD POLR1A NEDD4L TBL3 MYH14 DOCK7 PRKDC SNRNP200 | 8.58e-05 | 262 | 243 | 12 | int:LGR4 |
| Interaction | KRT78 interactions | 8.75e-05 | 87 | 243 | 7 | int:KRT78 | |
| Interaction | NUPR1 interactions | MYO5A SPTAN1 DDX5 P3H1 KIF5C ALDH1A1 NOP2 CAD POLR1A NUP107 NUP88 BAZ1B SRGAP2 CIT TBL3 CSNK2A1 DOCK7 PRKDC NHEJ1 SNRNP200 ZRANB1 | 8.76e-05 | 683 | 243 | 21 | int:NUPR1 |
| Interaction | CDK9 interactions | DNAJB12 MYO5A MYO10 SPTAN1 DDX5 AFF1 NOL7 ALDH1A1 NOP2 KRT2 KRT10 CAD NUP107 CASP8 CIT HEXIM2 MYH14 CSNK2A1 MRPS14 PRKDC ZRANB1 | 9.12e-05 | 685 | 243 | 21 | int:CDK9 |
| Interaction | KRT85 interactions | 9.22e-05 | 61 | 243 | 6 | int:KRT85 | |
| Interaction | ZNF112 interactions | 9.27e-05 | 8 | 243 | 3 | int:ZNF112 | |
| Interaction | FBXO22 interactions | USP9X RBM26 TBC1D2B OBSCN SIK1 TRANK1 MDN1 KIF19 ASCC2 AP3D1 POLR1A YTHDC2 APOE CIT CSNK2A1 IGHMBP2 CSNK2A3 ZRANB1 | 1.04e-04 | 540 | 243 | 18 | int:FBXO22 |
| Interaction | ANKRD36BP1 interactions | 1.05e-04 | 21 | 243 | 4 | int:ANKRD36BP1 | |
| Interaction | KRT20 interactions | 1.11e-04 | 63 | 243 | 6 | int:KRT20 | |
| Interaction | KRT5 interactions | 1.23e-04 | 193 | 243 | 10 | int:KRT5 | |
| Interaction | YWHAZ interactions | RALGAPA1 MYH11 MYO5A SPTAN1 RBM26 SPIRE1 SIK1 GFAP WWC2 SYNE2 KCNMA1 KATNIP MAP3K15 KIF5C ALDH2 KIF11 TBXA2R CAD NEDD4L KRT17 NUP107 ANKRD26 CNKSR2 SRGAP2 APOE FAM83H PTPDC1 DOCK7 ENO1 PCDH7 ZRANB1 NIN | 1.26e-04 | 1319 | 243 | 32 | int:YWHAZ |
| Interaction | SHC1 interactions | MYH11 USP9X SPTAN1 GFAP PTK2 DDX5 KRT2 KRT10 KRT13 CAD KRT17 MYH14 PRKDC SOS2 | 1.37e-04 | 362 | 243 | 14 | int:SHC1 |
| Interaction | KRT6A interactions | 1.44e-04 | 160 | 243 | 9 | int:KRT6A | |
| Interaction | KRT2 interactions | HAUS3 KRT40 KRT20 KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 FAM83H ZRANB1 | 1.45e-04 | 236 | 243 | 11 | int:KRT2 |
| Interaction | RAB4A interactions | RALGAPA1 MYO5A SPTAN1 TBC1D2B CC2D1A PGAM1 RABGAP1L SYNE2 EEA1 AP3D1 FMNL1 RABGGTA FAM234B SYNE1 VIPAS39 KIAA1217 | 1.45e-04 | 457 | 243 | 16 | int:RAB4A |
| Interaction | KRT1 interactions | GFAP FANCA KRT40 KRT2 KRT10 KRT13 KRT15 KRT17 KRT34 PCDH7 ZRANB1 | 1.56e-04 | 238 | 243 | 11 | int:KRT1 |
| Interaction | EFNA4 interactions | NEK10 GFAP KRT2 KRT10 KRT17 NUP107 KRT34 ARVCF PDE4DIP PRKDC XPO7 | 1.62e-04 | 239 | 243 | 11 | int:EFNA4 |
| Interaction | KRT77 interactions | 1.63e-04 | 96 | 243 | 7 | int:KRT77 | |
| Interaction | IQCB1 interactions | USP9X SPTAN1 PGAM1 ACAA2 KRT2 KRT10 CAD KRT15 KRT17 RNF135 IFT122 PRKDC ZRANB1 NIN | 1.71e-04 | 370 | 243 | 14 | int:IQCB1 |
| Interaction | FAM50B interactions | 1.84e-04 | 69 | 243 | 6 | int:FAM50B | |
| Interaction | KRT6B interactions | 2.03e-04 | 132 | 243 | 8 | int:KRT6B | |
| Interaction | SNAPIN interactions | 2.18e-04 | 169 | 243 | 9 | int:SNAPIN | |
| Interaction | CTNNB1 interactions | MYO5B USP9X SPTAN1 PTK2 DDX5 FANCA SYNE2 UQCRC1 ALDH1A1 CAD NAA15 NEDD4L ANKRD26 CASP8 APOE CIT RNF14 ABCG1 ARVCF MYH14 CSNK2A1 KIAA1217 PKN1 PRKDC ZRANB1 CDH9 | 2.26e-04 | 1009 | 243 | 26 | int:CTNNB1 |
| Interaction | SIRT6 interactions | USP9X DMAP1 FANCA FAT1 ASCC2 RPRD2 NOP2 FAT4 CAD POLR1A NUP107 NUP88 YTHDC2 TBL3 MYH14 PRKDC PCDH7 SNRNP200 ZRANB1 | 2.34e-04 | 628 | 243 | 19 | int:SIRT6 |
| Interaction | TRIM37 interactions | MYH2 MYO5A SPTAN1 TBC1D2 TBC1D2B PGAM1 UBE2U RPRD2 MGA CCDC33 KRT2 KRT10 NEDD4L NUP88 FAM83H MYH14 DOCK7 PRKDC ENO1 | 2.43e-04 | 630 | 243 | 19 | int:TRIM37 |
| Interaction | AGAP2 interactions | RALGAPA1 MYO5A USP9X SPTAN1 NCDN PTK2 KRT17 SYNE1 CNKSR2 PCDH7 | 2.44e-04 | 210 | 243 | 10 | int:AGAP2 |
| Interaction | OBSL1 interactions | XAB2 DDX5 FANCA MDN1 SYNE2 NLE1 MGA NOP2 DHX16 CAD POLR1A KRT17 NUP107 SYNE1 CECR2 BAZ1B CIT TBL3 DNAH1 CSNK2A1 MRPS14 PRKDC ENO1 SNRNP200 | 2.49e-04 | 902 | 243 | 24 | int:OBSL1 |
| Interaction | HOXB7 interactions | 2.50e-04 | 26 | 243 | 4 | int:HOXB7 | |
| Interaction | MINDY4 interactions | 2.51e-04 | 73 | 243 | 6 | int:MINDY4 | |
| Interaction | PRSS1 interactions | 2.51e-04 | 73 | 243 | 6 | int:PRSS1 | |
| Interaction | EFNA1 interactions | 2.52e-04 | 103 | 243 | 7 | int:EFNA1 | |
| Interaction | LHX5 interactions | 2.66e-04 | 11 | 243 | 3 | int:LHX5 | |
| Interaction | EIF3F interactions | LRRC49 DDX5 KCNMA1 ALDH1A1 KIF11 KRT2 KRT10 CIT CSNK2A1 PKN1 CSNK2A3 ZRANB1 | 2.67e-04 | 296 | 243 | 12 | int:EIF3F |
| Interaction | RNF208 interactions | 2.90e-04 | 75 | 243 | 6 | int:RNF208 | |
| Interaction | KRT84 interactions | 3.03e-04 | 49 | 243 | 5 | int:KRT84 | |
| Interaction | RNF6 interactions | 3.12e-04 | 76 | 243 | 6 | int:RNF6 | |
| Interaction | EAPP interactions | 3.12e-04 | 76 | 243 | 6 | int:EAPP | |
| Interaction | KRT6C interactions | 3.12e-04 | 76 | 243 | 6 | int:KRT6C | |
| Interaction | UTP14C interactions | 3.33e-04 | 50 | 243 | 5 | int:UTP14C | |
| Interaction | NAA40 interactions | RBM26 CC2D1A MCCC1 TTC1 XAB2 DDX5 RPRD2 NOP2 AP3D1 KIF11 WDR44 DHX16 NAA15 NUP107 NUP88 ANKRD26 BAZ1B YTHDC2 SRGAP2 CIT KIAA1217 PRKDC ENO1 SNRNP200 ZRANB1 | 3.37e-04 | 978 | 243 | 25 | int:NAA40 |
| Interaction | HAUS1 interactions | 3.92e-04 | 183 | 243 | 9 | int:HAUS1 | |
| Interaction | ACE2 interactions | RALGAPA1 GIN1 SPTAN1 CC2D1A GFAP DDX5 FAM83D NOL7 ADAM17 KIF5C ALDH1A1 EEA1 NOP2 AP3D1 WDR44 DHX16 KRT2 KRT10 CAD KRT17 TRIOBP BAZ1B APOE CIT PRKDC ENO1 SNRNP200 | 4.00e-04 | 1106 | 243 | 27 | int:ACE2 |
| Interaction | ARL4D interactions | 4.02e-04 | 146 | 243 | 8 | int:ARL4D | |
| Interaction | STAG2 interactions | 4.07e-04 | 224 | 243 | 10 | int:STAG2 | |
| Interaction | GOLGA6L6 interactions | 4.31e-04 | 3 | 243 | 2 | int:GOLGA6L6 | |
| Interaction | CIB2 interactions | 4.41e-04 | 81 | 243 | 6 | int:CIB2 | |
| Interaction | NIN interactions | CC2D1A HAUS3 CPLANE1 MGA AP3D1 RNF135 ANKRD26 CCDC77 CIT FAM83H KIAA1217 LRRCC1 NIN | 4.43e-04 | 359 | 243 | 13 | int:NIN |
| Cytoband | 17q21.2 | 3.94e-05 | 70 | 247 | 5 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 2.72e-04 | 473 | 247 | 10 | chr17q21 | |
| Cytoband | 19q13.2 | 2.77e-04 | 164 | 247 | 6 | 19q13.2 | |
| Cytoband | 17q21 | 3.80e-04 | 63 | 247 | 4 | 17q21 | |
| GeneFamily | Keratins, type I | 4.68e-09 | 28 | 165 | 7 | 608 | |
| GeneFamily | Myosin heavy chains | 8.44e-06 | 15 | 165 | 4 | 1098 | |
| GeneFamily | Non-clustered protocadherins | 1.55e-04 | 12 | 165 | 3 | 21 | |
| GeneFamily | Myosins, class V | 2.47e-04 | 3 | 165 | 2 | 1100 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.14e-04 | 36 | 165 | 4 | 823 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.40e-04 | 66 | 165 | 5 | 722 | |
| GeneFamily | Dyneins, axonemal | 4.62e-04 | 17 | 165 | 3 | 536 | |
| GeneFamily | Bisphosphoglycerate phosphatases | 4.91e-04 | 4 | 165 | 2 | 1082 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 4.91e-04 | 4 | 165 | 2 | 1252 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.16e-03 | 23 | 165 | 3 | 1288 | |
| GeneFamily | Plexins | 2.86e-03 | 9 | 165 | 2 | 683 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 4.31e-03 | 11 | 165 | 2 | 1168 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | RALGAPA1 FILIP1 MYH3 MYH11 MYO10 USP9X MRPL19 TENM2 PCDH17 TRPM5 KIF5C SLITRK6 CPLANE1 PCDH18 SEMA3F FAT4 CUX2 KRT15 NEDD4L LAMA3 BAZ1B SRGAP2 NFE2L3 IFT122 PCDH7 | 4.87e-06 | 806 | 239 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | FILIP1 MYH11 USP9X TENM2 PCDH17 SNX13 KCNMA1 KIF5C SLITRK6 CPLANE1 PCDH18 SEMA3F FAT4 KRT15 BAZ1B NFE2L3 | 1.69e-05 | 408 | 239 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SYCP2L MYO5B IKZF1 TENM2 PCDH17 FANCA TRPM5 SYNE2 ASCC2 KIF5C DMD SLITRK6 FMNL1 PLXNB1 CCDC33 CUX2 KRT15 NEDD4L CECR2 DOCK10 CCDC80 ABCG1 MYH14 BCAM CCDC171 ENO1 | 5.00e-05 | 984 | 239 | 26 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | GIN1 USP9X ZNF235 TRANK1 MDN1 RABGAP1L MAP3K15 CPLANE1 MGA WDR44 CAD NUP107 CECR2 NUP88 ANKRD26 YTHDC2 CNKSR2 SRBD1 DARS2 CAMKMT PRKDC NHEJ1 CCDC171 | 5.69e-05 | 820 | 239 | 23 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | FILIP1 MYH3 MYH11 MYO10 TENM2 PCDH17 SLITRK6 CPLANE1 SEMA3F FAT4 CUX2 KRT15 NEDD4L BAZ1B NFE2L3 | 6.30e-05 | 407 | 239 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | FAT1 TRANK1 P3H1 SYNE2 FAM83D ALDH1A1 DOCK10 KIAA1217 DOCK7 CCDC171 | 6.41e-05 | 191 | 239 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MYO5B GIN1 MYO10 SPIRE1 PCDH17 NRXN2 SYNE2 KIF5C DMD PHF21B NEDD4L CIT CCDC171 | 9.47e-05 | 328 | 239 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.14e-04 | 97 | 239 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | SYCP2L GIN1 SPIRE1 IKZF1 TENM2 PCDH17 FANCA TRPM5 FMN1 KIF5C DMD SLITRK6 FMNL1 CUX2 KRT13 KRT15 CECR2 DOCK10 ANKRD26 BAZ1B CCDC80 CNKSR2 SRGAP2 MYH14 LRRCC1 | 1.18e-04 | 978 | 239 | 25 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SYCP2L MYO5B GIN1 MYO10 SPIRE1 PCDH17 FANCA TRPM5 MDN1 NRXN2 RABGAP1L SYNE2 KATNIP KIF5C DMD SLITRK6 PHF21B NEDD4L CECR2 ANKRD26 FANCM CIT PALS1 LRRCC1 CCDC171 | 1.28e-04 | 983 | 239 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | SYCP2L IKZF1 TENM2 PCDH17 FANCA TRPM5 DMD SLITRK6 FMNL1 CUX2 KRT15 CECR2 DOCK10 CCDC80 MYH14 ENO1 | 1.44e-04 | 489 | 239 | 16 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.76e-04 | 104 | 239 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#1 | 1.81e-04 | 47 | 239 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | USP9X C3orf38 LRRC49 RBM26 HAUS3 PCDH17 SLC12A5 MDN1 SYNE2 AFF1 KIF5C SLITRK6 CPLANE1 PCDH18 FMNL1 FCHSD1 NEDD4L NUP88 ANKRD26 E2F1 CNKSR2 CCDC77 FANCM CIT MYH14 CSNK2A1 DOCK7 LRRCC1 IFT122 | 1.83e-04 | 1252 | 239 | 29 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SYCP2L MYO5A GIN1 MYO10 USP9X LRRC49 RBM26 SPIRE1 HAUS3 DCUN1D4 MDN1 SYNE2 KRT20 KIF5C DMD CPLANE1 PHF21B KIF11 GCFC2 NEDD4L CECR2 ANKRD26 BAZ1B E2F1 CCDC77 FANCM CIT ARVCF MYH14 DOCK7 LRRCC1 NHEJ1 | 2.25e-04 | 1459 | 239 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | LRRC49 ZNF227 BGN WWC2 SYNE2 ALDH1A1 ALDH2 KIF11 ARHGEF12 HEATR5A APOE DOCK7 LRRCC1 PCDH7 | 2.37e-04 | 409 | 239 | 14 | GSM476663_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | SYCP2L MYO5B RETSAT TENM2 PCDH17 FANCA TRPM5 RABGAP1L DMD SLITRK6 FMNL1 PLXNB1 CUX2 KRT15 CECR2 DOCK10 CCDC80 IER2 ABCG1 MYH14 KIAA1217 BCAM CCDC171 ENO1 | 2.76e-04 | 973 | 239 | 24 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | MYH3 MYO5B TENM2 PCDH17 FANCA TRPM5 NRXN2 FMN1 RABGAP1L ACAA2 DMD SLITRK6 FMNL1 FAM234B CUX2 KRT13 KRT15 DOCK10 CASP8 CCDC80 CNKSR2 MYH14 CCDC171 CCDC63 | 2.76e-04 | 973 | 239 | 24 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | DGKH TENM2 FAT1 SPOCK3 SYNE2 SLITRK6 PLXNB1 KRT13 KRT15 KRT17 CCDC80 KIAA1217 PCDH7 | 8.85e-11 | 197 | 247 | 13 | 24360b660000bdfb999d58fbf4e29585a97e1785 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B SIK1 UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 ARHGEF1 BCAM | 1.33e-09 | 199 | 247 | 12 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B SIK1 UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 ARHGEF1 BCAM | 1.41e-09 | 200 | 247 | 12 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DGKH SYNE2 ALDH1A1 CPLANE1 ADGRF1 PLXNB1 ARHGEF12 CCDC80 MYH14 KIAA1217 BCAM PCDH7 | 1.41e-09 | 200 | 247 | 12 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FILIP1 MYH11 MYO10 TBC1D2B OBSCN DGKH BGN FAT1 DMD PCDH18 CDH19 | 8.02e-09 | 186 | 247 | 11 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | TENM2 FAT1 SPOCK3 SLITRK6 PLXNB1 KRT13 KRT15 KRT17 CCDC80 KIAA1217 PCDH7 | 1.06e-08 | 191 | 247 | 11 | a98915bad9a4a61dd4cbca798914849b805f4a19 |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | DGKH SPOCK3 SYNE2 ALDH1A1 SLITRK6 KRT15 KRT17 LAMA3 KIAA1217 BCAM PCDH7 | 1.53e-08 | 198 | 247 | 11 | f5b7013045b61fc56894f80092f799770dde1c8f |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B SIK1 UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 BCAM | 1.53e-08 | 198 | 247 | 11 | 85f424cd9bb3117c9e322031024aabb87696ce47 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 ARHGEF1 BCAM | 1.62e-08 | 199 | 247 | 11 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | MYH11 MYO10 OBSCN DGKH BGN FAT1 SYNE2 DMD PCDH18 CNKSR2 CDH19 | 1.70e-08 | 200 | 247 | 11 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 ARHGEF1 BCAM | 1.70e-08 | 200 | 247 | 11 | 8683445ad5b70748c4a1f12eb77d47623085147e |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYH11 MYO10 OBSCN DGKH BGN FAT1 SYNE2 DMD PCDH18 CNKSR2 CDH19 | 1.70e-08 | 200 | 247 | 11 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MYH11 MYO10 OBSCN DGKH BGN FAT1 SYNE2 DMD PCDH18 CNKSR2 CDH19 | 1.70e-08 | 200 | 247 | 11 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DGKH SYNE2 ALDH1A1 CPLANE1 ADGRF1 PLXNB1 ARHGEF12 MYH14 KIAA1217 BCAM PCDH7 | 1.70e-08 | 200 | 247 | 11 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-08 | 185 | 247 | 10 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FILIP1 TBC1D2 UNC13D WWC2 NEDD4L KRT17 LAMA3 MYH14 KIAA1217 BCAM | 1.00e-07 | 187 | 247 | 10 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | FILIP1 NEK10 OBSCN LRRC2 TENM2 RABGAP1L B4GALNT3 DMD PDE4DIP PCDH7 | 1.16e-07 | 190 | 247 | 10 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | FILIP1 NEK10 OBSCN LRRC2 TENM2 RABGAP1L B4GALNT3 DMD PDE4DIP PCDH7 | 1.22e-07 | 191 | 247 | 10 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | DGKH TENM2 FAT1 SYNE2 SLITRK6 PLXNB1 KRT13 KRT15 KRT17 PCDH7 | 1.55e-07 | 196 | 247 | 10 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | OBSCN DGKH TENM2 FAT1 SPOCK3 SLITRK6 KRT15 KRT17 KIAA1217 PCDH7 | 1.63e-07 | 197 | 247 | 10 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 BCAM | 1.70e-07 | 198 | 247 | 10 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B SIK1 UNC13D WWC2 SYNE2 LAMA3 HEATR5A MYH14 BCAM | 1.70e-07 | 198 | 247 | 10 | 9b161285df7a4e51618f3517cfc5b8221ba55786 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-07 | 198 | 247 | 10 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | OBSCN DGKH SPOCK3 SLITRK6 SEMA3F KRT15 KRT17 LAMA3 BCAM PCDH7 | 1.79e-07 | 199 | 247 | 10 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FILIP1 MYO5B UNC13D WWC2 SYNE2 PLXNB1 LAMA3 HEATR5A MYH14 BCAM | 1.79e-07 | 199 | 247 | 10 | a270630626df614f8605abddb7dee7c4d74f6149 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | MYO5B UNC13D WWC2 SYNE2 PLXNB1 CECR2 LAMA3 HEATR5A MYH14 BCAM | 1.87e-07 | 200 | 247 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FAT1 SPOCK3 KRT40 SLITRK6 KRT15 KRT17 LAMA3 KIAA1217 BCAM PCDH7 | 1.87e-07 | 200 | 247 | 10 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 4.79e-07 | 170 | 247 | 9 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.11e-07 | 175 | 247 | 9 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | LRRC2 TENM2 PHF21B PPFIA4 ARHGEF12 SRGAP2 PALS1 PDE4DIP SRGAP2B | 8.88e-07 | 183 | 247 | 9 | 3c516fe5083f02bad1f464ed284010b4131a833c |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 8.88e-07 | 183 | 247 | 9 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.88e-07 | 183 | 247 | 9 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | LRRC2 TENM2 PHF21B PPFIA4 ARHGEF12 SRGAP2 PALS1 PDE4DIP SRGAP2B | 8.88e-07 | 183 | 247 | 9 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 184 | 247 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 184 | 247 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 184 | 247 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | SPOCK3 B4GALNT3 SLITRK6 PLXNB1 KRT15 NEDD4L KRT17 KIAA1217 BCAM | 1.06e-06 | 187 | 247 | 9 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 189 | 247 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | FILIP1 OBSCN LRRC2 TENM2 DMD ARHGEF12 KIAA1217 PDE4DIP PCDH7 | 1.16e-06 | 189 | 247 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.16e-06 | 189 | 247 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.21e-06 | 190 | 247 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 191 | 247 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 191 | 247 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | FILIP1 MYO5B WWC2 B4GALNT3 NEDD4L CECR2 LAMA3 MYH14 KIAA1217 | 1.27e-06 | 191 | 247 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 191 | 247 | 9 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 191 | 247 | 9 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.32e-06 | 192 | 247 | 9 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-06 | 193 | 247 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.50e-06 | 195 | 247 | 9 | 6800c17026ec6c56132bf4664b8fcd74d7836579 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-06 | 196 | 247 | 9 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | PTK2 SYNE2 NEDD4L SYNE1 ARHGEF12 CCDC80 DNAH7 KIAA1217 DNAH11 | 1.57e-06 | 196 | 247 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | PTK2 SYNE2 NEDD4L SYNE1 ARHGEF12 CCDC80 DNAH7 KIAA1217 DNAH11 | 1.57e-06 | 196 | 247 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 197 | 247 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 198 | 247 | 9 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 198 | 247 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 198 | 247 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-06 | 199 | 247 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 247 | 9 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-06 | 200 | 247 | 9 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-06 | 200 | 247 | 9 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.85e-06 | 200 | 247 | 9 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 247 | 9 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.92e-06 | 158 | 247 | 8 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.02e-06 | 170 | 247 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.41e-06 | 122 | 247 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-06 | 177 | 247 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-06 | 178 | 247 | 8 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.04e-06 | 178 | 247 | 8 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 7.33e-06 | 179 | 247 | 8 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | CF-Myeloid-Alveolar_Macrophage|CF / Disease state, Lineage and Cell class | 7.64e-06 | 180 | 247 | 8 | 6a7c3a3f3a16ca9f109047adaf36f6a2746d6ab9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 181 | 247 | 8 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 7.95e-06 | 181 | 247 | 8 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 181 | 247 | 8 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 181 | 247 | 8 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 8.28e-06 | 182 | 247 | 8 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 183 | 247 | 8 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 183 | 247 | 8 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.97e-06 | 184 | 247 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.97e-06 | 184 | 247 | 8 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-06 | 185 | 247 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.33e-06 | 185 | 247 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-06 | 185 | 247 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-06 | 185 | 247 | 8 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.70e-06 | 186 | 247 | 8 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 247 | 8 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 187 | 247 | 8 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 188 | 247 | 8 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 189 | 247 | 8 | 7b6cb745c0a637d6addc105a79059ed488fced39 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.09e-05 | 189 | 247 | 8 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.13e-05 | 190 | 247 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.13e-05 | 190 | 247 | 8 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 190 | 247 | 8 | 86ab845a7fae2111c0b01e1aec235e19c4c0ef5c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.13e-05 | 190 | 247 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.13e-05 | 190 | 247 | 8 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-05 | 190 | 247 | 8 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 191 | 247 | 8 | eec14997d2bfc7e6b5a601afc43a147f6b96d668 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 191 | 247 | 8 | 1730ec5dc1cfd2f0cba7e21555641c7bce97e09d | |
| Computational | Intermediate filaments and MT. | 5.81e-06 | 68 | 156 | 8 | MODULE_438 | |
| Drug | S-(-)-Etomoxir | 1.24e-07 | 100 | 244 | 10 | CID000060765 | |
| Drug | CK17 | 1.63e-07 | 57 | 244 | 8 | CID000128831 | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | SNX13 BGN SPOCK3 NLE1 KIF5C CUX2 GCFC2 BAZ1B YTHDC2 APOE MYH14 IGHMBP2 SNRNP200 | 2.39e-07 | 198 | 244 | 13 | 2947_UP |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | SPTAN1 SIK1 XAB2 FANCA CCDC33 TBXA2R CASS4 SEMA3F NRF1 MAFK CNKSR2 KLHL22 ARVCF | 2.68e-07 | 200 | 244 | 13 | 6963_UP |
| Drug | olomoucine II | 3.49e-07 | 27 | 244 | 6 | CID005494414 | |
| Drug | formycin triphosphate | 1.15e-06 | 51 | 244 | 7 | CID000122274 | |
| Drug | Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A | RALGAPA1 SPTAN1 ZNF227 SNX13 ACAA2 AP3D1 FAT4 CASP8 FEM1B PDE4DIP PRKDC SOS2 | 1.25e-06 | 193 | 244 | 12 | 6704_DN |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | DNAJB12 MYO10 RBM26 CC2D1A XAB2 SPOCK3 GLG1 ALDH2 GCFC2 E2F1 KLHL22 SOS2 | 1.25e-06 | 193 | 244 | 12 | 2505_DN |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | TBC1D2B IKZF1 FANCA SPOCK3 KRT20 NLE1 ADAM17 TBXA2R NRF1 ARHGEF1 PDE4DIP SOS2 | 1.47e-06 | 196 | 244 | 12 | 6666_DN |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | RALGAPA1 SPTAN1 NCDN FANCA AP3D1 PLXNB1 RAPSN NEDD4L BAZ1B CASP8 DNAH7 SOS2 | 1.47e-06 | 196 | 244 | 12 | 6708_DN |
| Drug | purealin | 2.81e-06 | 58 | 244 | 7 | CID006419303 | |
| Drug | CK 6 | 2.81e-06 | 58 | 244 | 7 | CID000447960 | |
| Drug | NSC339663 | MYH2 MYH3 MYH11 MYO5A MYO5B MYO10 PTK2 TLX2 SYNE2 EEA1 SYNE1 TRIOBP MYH14 | 3.30e-06 | 250 | 244 | 13 | CID000003892 |
| Drug | TRAM-34 | 6.23e-06 | 43 | 244 | 6 | CID000656734 | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A | RALGAPA1 SPOCK3 RABGAP1L EEA1 SEMA3F FAT4 RAPSN TRIOBP DNAH7 ARHGEF1 SOS2 | 8.00e-06 | 193 | 244 | 11 | 6699_DN |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | ACOX2 SPOCK3 KCNMA1 PLXNB1 SEMA3F DOCK10 ARHGEF12 BAZ1B TEP1 DNAH7 KLHL36 | 9.26e-06 | 196 | 244 | 11 | 4276_DN |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | CTSF GFAP ACOX2 TBXA2R SEMA3F DOCK10 BAZ1B ARVCF MYH14 PDE4DIP BCAM | 9.72e-06 | 197 | 244 | 11 | 4121_UP |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | DNAJB12 SNX13 WWC2 SPOCK3 GLG1 KIF5C GCFC2 KRT15 ARHGEF12 CSNK2A1 PDE4DIP | 9.72e-06 | 197 | 244 | 11 | 4266_DN |
| Drug | splitomicin; Down 200; 20uM; PC3; HG-U133A | MYOC TBC1D2B BGN GLG1 ALDH2 FAM234B NEDD4L PKD2L1 APOE ARVCF PCDH7 | 1.02e-05 | 198 | 244 | 11 | 661_DN |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | TBC1D2B IKZF1 ZNF227 BGN NRF1 SHMT1 BAZ1B PKD2L1 ABCG1 PDE4DIP IFT122 | 1.02e-05 | 198 | 244 | 11 | 6352_UP |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | TBC1D2 SNX13 SPOCK3 GLG1 KCNMA1 SMG6 KRT15 ANKRD26 PDE4DIP PCDH7 SOS2 | 1.02e-05 | 198 | 244 | 11 | 2622_UP |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | CTSF SPTAN1 CC2D1A KRT20 RPRD2 AP3D1 TBXA2R KRT15 DNAH7 KLHL22 PCDH7 | 1.02e-05 | 198 | 244 | 11 | 4194_DN |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | SPTAN1 XAB2 BGN WWC2 PLXNB1 PLXNA3 GCFC2 BAZ1B E2F1 MYH14 CAMKMT | 1.07e-05 | 199 | 244 | 11 | 7020_UP |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | TBC1D2 SNX13 GLG1 ALDH2 PLXNA3 YTHDC2 APOE ARVCF MYH14 KLHL36 CAMKMT | 1.07e-05 | 199 | 244 | 11 | 2956_UP |
| Drug | NSC34533 | 2.39e-05 | 54 | 244 | 6 | CID000003512 | |
| Drug | blebbistatin | 3.64e-05 | 116 | 244 | 8 | CID003476986 | |
| Drug | B0683 | 3.87e-05 | 117 | 244 | 8 | CID006398969 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | SPTAN1 TBC1D2 PCDH17 KIF5C AMIGO2 APOE ABCG1 ARVCF KLHL36 PDE4DIP | 4.28e-05 | 191 | 244 | 10 | 2137_UP |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | RALGAPA1 RETSAT ACOX2 SEMA3F PLXNA3 FAT4 SYNE1 TRIOBP BAZ1B CAMKMT | 4.48e-05 | 192 | 244 | 10 | 2123_UP |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | DNAJB12 SPTAN1 PTK2 ADAM17 FMNL1 CUX2 DOCK10 SHMT1 MYH14 PDE4DIP | 4.48e-05 | 192 | 244 | 10 | 2572_UP |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | SPTAN1 SNX13 RABGAP1L PLXNB1 SEMA3F ARHGEF12 CNKSR2 ARVCF PDE4DIP SOS2 | 4.68e-05 | 193 | 244 | 10 | 7341_UP |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | ZNF227 DCUN1D4 SNX13 CPLANE1 NRF1 PPFIA4 CASP8 IGHMBP2 CAMKMT SNRNP200 | 4.68e-05 | 193 | 244 | 10 | 4583_UP |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | ZNF224 GMIP SEMA3F NRF1 ARHGEF12 BAZ1B APOE TEP1 KLHL22 PDE4DIP | 5.10e-05 | 195 | 244 | 10 | 3670_DN |
| Drug | 4-hydroxycyclophosphamide | 5.10e-05 | 38 | 244 | 5 | CID000099735 | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | TBC1D2 XAB2 BGN FANCA SMG6 KRT10 ANKRD26 TRIOBP CASP8 IGHMBP2 | 5.33e-05 | 196 | 244 | 10 | 3353_DN |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | RALGAPA1 TBC1D2 GLG1 ACAA2 ADAM17 SEMA3F NRF1 BAZ1B CASP8 SOS2 | 5.33e-05 | 196 | 244 | 10 | 2291_DN |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | SIK1 ZNF224 NLE1 SEMA3F NEDD4L NRF1 LAMA3 CASP8 ARVCF ARHGEF1 | 5.33e-05 | 196 | 244 | 10 | 5331_UP |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | NCDN KCNMA1 IMPG2 RAPSN E2F1 ARVCF ARHGEF1 IGHMBP2 PDE4DIP SOS2 | 5.56e-05 | 197 | 244 | 10 | 6106_DN |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | DNAJB12 CTSF ACOX1 TBC1D2 PCDH17 SLC12A5 ARHGEF12 YTHDC2 ARVCF PCDH7 | 5.56e-05 | 197 | 244 | 10 | 4949_UP |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | TBC1D2B FANCA KRT20 ALDH2 DMD TBXA2R SEMA3F CNKSR2 KLHL22 MYH14 | 5.56e-05 | 197 | 244 | 10 | 5045_UP |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | STAG1 CC2D1A KIF5C SEMA3F SYNE1 E2F1 SRGAP2 TEP1 KLHL36 PDE4DIP | 5.56e-05 | 197 | 244 | 10 | 7069_DN |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | DNAJB12 SPTAN1 PCDH17 IMPG2 TBXA2R DOCK10 CASP8 E2F1 APOE SOS2 | 5.56e-05 | 197 | 244 | 10 | 4017_UP |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | MYO10 MDN1 NEDD4L LAMA3 SHMT1 TRIOBP FEM1B MYH14 PDE4DIP SOS2 | 5.56e-05 | 197 | 244 | 10 | 5482_DN |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | RALGAPA1 SPTAN1 IKZF1 NLE1 ADAM17 PLXNB1 SEMA3F NRF1 LAMA3 PDE4DIP | 5.80e-05 | 198 | 244 | 10 | 5393_DN |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | IMPDH1 GIN1 DCUN1D4 NCDN PTK2 ADAM17 EEA1 ANKRD26 BAZ1B IGHMBP2 | 5.80e-05 | 198 | 244 | 10 | 1340_DN |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; PC3; HT_HG-U133A | RALGAPA1 DNAJB12 RBM26 TBC1D2B RABGAP1L SEMA3F KRT2 APOE ARVCF PCDH7 | 6.05e-05 | 199 | 244 | 10 | 5795_UP |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | RALGAPA1 DNAJB12 SPTAN1 TBC1D2 BGN SLC12A5 NLE1 BAZ1B CASP8 KLHL22 | 6.05e-05 | 199 | 244 | 10 | 6775_UP |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 6.05e-05 | 199 | 244 | 10 | 4957_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | DNAJB12 SNX13 TLX2 KCNMA1 TBXA2R CASS4 SEMA3F FAM234B APOE SOS2 | 6.31e-05 | 200 | 244 | 10 | 6701_UP |
| Drug | 1,4-Aptd | 6.54e-05 | 8 | 244 | 3 | CID000152126 | |
| Drug | sulfur mustard | 8.19e-05 | 130 | 244 | 8 | CID000010461 | |
| Drug | homocysteine thiolactone | 8.64e-05 | 131 | 244 | 8 | CID000107712 | |
| Drug | 4-dimethylaminocinnamaldehyde | 1.14e-04 | 2 | 244 | 2 | ctd:C018523 | |
| Drug | tert-butyl hydroperoxide | MYO5A MYO10 SIK1 ZNF227 RETSAT PTK2 GLG1 ALDH1A1 ALDH2 AP3D1 NSMAF AMIGO2 TBXA2R NAA15 NEDD4L NRF1 SHMT1 TRIOBP BAZ1B E2F1 APOE IER2 IFT122 | 1.15e-04 | 902 | 244 | 23 | CID000006410 |
| Drug | nitrosobenzylmethylamine | MYO5B TTC1 PGAM1 DDX5 FAT1 KRT20 ACAA2 ALDH1A1 ALDH2 KRT15 KRT17 NUP107 APOE TEP1 ABCG1 CSNK2A1 ENO1 | 1.26e-04 | 561 | 244 | 17 | ctd:C014707 |
| Drug | clenbuterol | 1.52e-04 | 142 | 244 | 8 | CID000002783 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 182 | 244 | 9 | 3887_DN | |
| Drug | 1pxm | 1.92e-04 | 78 | 244 | 6 | CID000447959 | |
| Drug | AC1NOEF6 | 2.15e-04 | 28 | 244 | 4 | CID005086914 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.20e-04 | 190 | 244 | 9 | 2375_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.29e-04 | 191 | 244 | 9 | 2499_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 244 | 9 | 6693_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A | PCDH17 GLG1 ALDH2 FAM234B ANKRD26 ARHGEF12 CASP8 PDE4DIP SOS2 | 2.29e-04 | 191 | 244 | 9 | 5792_DN |
| Drug | Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 244 | 9 | 6746_DN | |
| Drug | AC1L9MJT | 2.38e-04 | 192 | 244 | 9 | CID000448959 | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 2.38e-04 | 192 | 244 | 9 | 4151_UP | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 2.38e-04 | 192 | 244 | 9 | 5101_UP | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 2.47e-04 | 193 | 244 | 9 | 881_UP | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.47e-04 | 193 | 244 | 9 | 5726_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | DNAJB12 TBC1D2 SLC12A5 FANCA SPOCK3 GLG1 KCNMA1 NEDD4L PPFIA4 | 2.47e-04 | 193 | 244 | 9 | 4322_UP |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | DNAJB12 CC2D1A BGN NRXN2 KCNMA1 TBXA2R ARHGEF12 BAZ1B PDE4DIP | 2.57e-04 | 194 | 244 | 9 | 6673_UP |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 4272_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 4429_DN | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | RALGAPA1 ZNF224 ZNF235 SPOCK3 KIF5C PLXNB1 FAT4 ARHGEF1 SOS2 | 2.57e-04 | 194 | 244 | 9 | 7545_DN |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 244 | 9 | 6729_DN | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 6074_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 7219_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A | SPTAN1 CC2D1A SPOCK3 EEA1 TBXA2R PLXNA3 SHMT1 IGHMBP2 PDE4DIP | 2.67e-04 | 195 | 244 | 9 | 7394_UP |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 2425_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4345_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4360_DN | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; PC3; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4611_DN | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | SPTAN1 ZNF224 ZNF235 RABGAP1L KIF5C SMG6 ARHGEF12 IGHMBP2 SOS2 | 2.67e-04 | 195 | 244 | 9 | 7372_UP |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 2707_DN | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 195 | 244 | 9 | 4763_UP | |
| Drug | liu | MYO5A MYO10 MCCC1 PTK2 KCNMA1 ADAM17 NAA15 E2F1 APOE PKN1 BCAM | 2.71e-04 | 285 | 244 | 11 | CID015991562 |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; HL60; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 3076_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 2236_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 1168_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 3872_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; HL60; HG-U133A | 2.77e-04 | 196 | 244 | 9 | 1967_UP | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 3390_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 1301_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 5947_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | RALGAPA1 DNAJB12 TBC1D2 KCNMA1 AFF1 ACAA2 EEA1 YTHDC2 IGHMBP2 | 2.77e-04 | 196 | 244 | 9 | 4724_UP |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; HL60; HT_HG-U133A | 2.77e-04 | 196 | 244 | 9 | 2553_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 244 | 9 | 5518_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 244 | 9 | 3899_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.88e-04 | 197 | 244 | 9 | 6389_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | RALGAPA1 TBC1D2 TBC1D2B ZNF224 SNX13 BAZ1B CASP8 YTHDC2 KLHL22 | 2.88e-04 | 197 | 244 | 9 | 2285_DN |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 2.03e-06 | 4 | 237 | 3 | EFO_0022116 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.74e-06 | 13 | 237 | 4 | EFO_0800413 | |
| Disease | cholesterol to total lipids in small HDL percentage | 3.35e-06 | 51 | 237 | 6 | EFO_0022240 | |
| Disease | Metastatic melanoma | 4.72e-06 | 54 | 237 | 6 | C0278883 | |
| Disease | triglycerides in medium HDL measurement | 4.72e-06 | 54 | 237 | 6 | EFO_0022321 | |
| Disease | apolipoprotein B measurement | STAG1 ZNF224 ZNF112 ZNF235 PTK2 SYNE2 AFF1 B4GALNT3 NSMAF RAPSN BAZ1B PKD2L1 APOE ZNF284 NFE2L3 DOCK7 BCAM DNAH11 | 7.90e-06 | 663 | 237 | 18 | EFO_0004615 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.27e-05 | 144 | 237 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | hemoglobin A1 measurement | UNC13D DCUN1D4 SYNE2 ASCC2 MAP3K15 MGA SMG6 RAPSN CASP8 PKD2L1 SRGAP2 PNKD ARVCF SNRNP200 SOS2 | 2.29e-05 | 520 | 237 | 15 | EFO_0007629 |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.40e-05 | 43 | 237 | 5 | EFO_0022254 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.97e-05 | 243 | 237 | 10 | EFO_0004612, EFO_0020944 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.04e-05 | 150 | 237 | 8 | EFO_0004611, EFO_0020947 | |
| Disease | lipoprotein A measurement | 3.50e-05 | 112 | 237 | 7 | EFO_0006925 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.50e-05 | 153 | 237 | 8 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.72e-05 | 200 | 237 | 9 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 3.72e-05 | 200 | 237 | 9 | EFO_0000195 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.99e-05 | 78 | 237 | 6 | EFO_0022187 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 5.89e-05 | 10 | 237 | 3 | OBA_2045075 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 5.89e-05 | 10 | 237 | 3 | EFO_0800333 | |
| Disease | triglycerides in HDL measurement | 6.72e-05 | 53 | 237 | 5 | EFO_0022317 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.14e-05 | 28 | 237 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | cholesterol to total lipids in large HDL percentage | 8.04e-05 | 55 | 237 | 5 | EFO_0022234 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 8.05e-05 | 11 | 237 | 3 | EFO_0800332 | |
| Disease | body weight | RALGAPA1 C3orf38 RGPD1 DGKH TTC1 DCUN1D4 SPOCK3 RABGAP1L DMD MGA CUX2 RAPSN POLR1A NUP88 ARHGEF12 CNKSR2 CDH19 KIAA1217 CAMKMT CCDC171 PCDH7 ZRANB1 CDH9 XPO7 | 8.80e-05 | 1261 | 237 | 24 | EFO_0004338 |
| Disease | phospholipids:total lipids ratio | 9.87e-05 | 227 | 237 | 9 | EFO_0020946 | |
| Disease | alcohol consumption measurement, alcohol drinking | 1.07e-04 | 12 | 237 | 3 | EFO_0004329, EFO_0007878 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.22e-04 | 60 | 237 | 5 | EFO_0021898 | |
| Disease | coffee consumption | 1.22e-04 | 32 | 237 | 4 | EFO_0004330 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.38e-04 | 13 | 237 | 3 | OBA_2045159 | |
| Disease | free cholesterol in very large HDL measurement | 1.43e-04 | 62 | 237 | 5 | EFO_0022273 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.43e-04 | 62 | 237 | 5 | EFO_0022263 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.51e-04 | 99 | 237 | 6 | EFO_0004611, EFO_0007878 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 1.56e-04 | 34 | 237 | 4 | EFO_0004458, EFO_0004612 | |
| Disease | carbohydrate intake measurement | 1.56e-04 | 34 | 237 | 4 | EFO_0010811 | |
| Disease | basophil count | IKZF1 GMIP GLG1 AFF1 NSMAF CUX2 TRIOBP PKD2L1 PNKD CIT ARVCF PRKDC ENO1 | 1.60e-04 | 483 | 237 | 13 | EFO_0005090 |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 TENM2 WWC2 TRANK1 AFF1 ALDH2 NSMAF CUX2 NEDD4L DNAJC30 RNF135 TRIOBP BAZ1B CASP8 APOE PNKD CIT NFE2L3 CCDC171 | 1.63e-04 | 914 | 237 | 19 | EFO_0004532 |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.69e-04 | 101 | 237 | 6 | EFO_0004530, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.78e-04 | 102 | 237 | 6 | EFO_0004329, EFO_0004611 | |
| Disease | age at menopause | SYCP2L RBM26 HLA-F DCUN1D4 MGA NOBOX DOCK10 FANCM PRKDC ZRANB1 | 1.80e-04 | 302 | 237 | 10 | EFO_0004704 |
| Disease | Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) measurement | 1.92e-04 | 3 | 237 | 2 | EFO_0022111 | |
| Disease | drinking behavior | 1.92e-04 | 3 | 237 | 2 | EFO_0004315 | |
| Disease | 1-oleoyl-2-docosapentaenoyl-GPC (18:1/22:5n3) measurement | 1.92e-04 | 3 | 237 | 2 | EFO_0800487 | |
| Disease | N-palmitoyl-sphinganine (d18:0/16:0) measurement | 1.92e-04 | 3 | 237 | 2 | EFO_0800428 | |
| Disease | sleep duration, triglyceride measurement | 1.98e-04 | 104 | 237 | 6 | EFO_0004530, EFO_0005271 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 2.18e-04 | 37 | 237 | 4 | EFO_0022252 | |
| Disease | fatty acid measurement | STAG1 MYO10 GMIP AFF1 ACAA2 RAPSN BAZ1B PKD2L1 APOE NFE2L3 DOCK7 CCDC171 | 2.33e-04 | 436 | 237 | 12 | EFO_0005110 |
| Disease | bilirubin measurement | STAG1 AFF1 IP6K2 SMG6 FAT4 CUX2 RAPSN APOE DOCK7 CCDC171 DNAH11 SOS2 | 2.63e-04 | 442 | 237 | 12 | EFO_0004570 |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 2.65e-04 | 16 | 237 | 3 | EFO_0800184 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.76e-04 | 206 | 237 | 8 | EFO_0004612, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.04e-04 | 264 | 237 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | C-reactive protein measurement | MYH2 DGKH ZNF227 ZNF112 TLR8 PCDH17 FANCA TRANK1 SLITRK6 IP6K2 SEMA3F CUX2 CAD RAPSN BAZ1B YTHDC2 APOE CIT DOCK7 BCAM CCDC171 DNAH11 | 3.14e-04 | 1206 | 237 | 22 | EFO_0004458 |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 3.57e-04 | 42 | 237 | 4 | EFO_0022255 | |
| Disease | Adenocarcinoma | 3.58e-04 | 116 | 237 | 6 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 3.58e-04 | 116 | 237 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.58e-04 | 116 | 237 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.58e-04 | 116 | 237 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.58e-04 | 116 | 237 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.58e-04 | 116 | 237 | 6 | C0205641 | |
| Disease | Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) measurement | 3.81e-04 | 4 | 237 | 2 | EFO_0022112 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.81e-04 | 4 | 237 | 2 | cv:CN293514 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 3.82e-04 | 18 | 237 | 3 | OBA_2045155 | |
| Disease | triacylglycerol 56:3 measurement | 3.82e-04 | 18 | 237 | 3 | EFO_0010430 | |
| Disease | triglycerides in large LDL measurement | 3.92e-04 | 43 | 237 | 4 | EFO_0022319 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.93e-04 | 118 | 237 | 6 | EFO_0010119 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.99e-04 | 274 | 237 | 9 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.21e-04 | 276 | 237 | 9 | EFO_0004612, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.49e-04 | 121 | 237 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | Squamous cell carcinoma | 5.11e-04 | 124 | 237 | 6 | C0007137 | |
| Disease | apolipoprotein A 1 measurement | STAG1 MYO5B UNC13D IKZF1 SNX13 TRANK1 AFF1 ACAA2 MGA RABGGTA SMG6 RAPSN APOE VIPAS39 CSNK2A1 DOCK7 BCAM | 5.42e-04 | 848 | 237 | 17 | EFO_0004614 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.80e-04 | 127 | 237 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 6.11e-04 | 21 | 237 | 3 | OBA_2045156 | |
| Disease | saturated fatty acids to total fatty acids percentage | 6.11e-04 | 21 | 237 | 3 | EFO_0022305 | |
| Disease | Sphingomyelin (d18:1/20:0, d16:1/22:0) measurement | 6.32e-04 | 5 | 237 | 2 | EFO_0022109 | |
| Disease | cholesterol:total lipids ratio, cholesteryl esters:total lipids ratio | 6.32e-04 | 5 | 237 | 2 | EFO_0020943, EFO_0020944 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 6.32e-04 | 5 | 237 | 2 | C0410190 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 6.32e-04 | 5 | 237 | 2 | C1450051 | |
| Disease | Pachyonychia Congenita | 6.32e-04 | 5 | 237 | 2 | C0265334 | |
| Disease | glycerophospholipid measurement | 6.47e-04 | 49 | 237 | 4 | EFO_0007630 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.58e-04 | 86 | 237 | 5 | EFO_0008595, EFO_0020945 | |
| Disease | non-alcoholic fatty liver disease | 7.02e-04 | 182 | 237 | 7 | EFO_0003095 | |
| Disease | non-high density lipoprotein cholesterol measurement | ZNF235 RABGAP1L SYNE2 AFF1 B4GALNT3 PLXNA3 RAPSN RNF135 HEATR5A APOE PNKD NFE2L3 DOCK7 CAMKMT DNAH11 | 7.05e-04 | 713 | 237 | 15 | EFO_0005689 |
| Disease | Alzheimer's disease (is_implicated_in) | 7.11e-04 | 132 | 237 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | platelet crit | STAG1 IKZF1 AFF1 RPRD2 UQCRC1 ALDH2 SMG6 CASS4 RAPSN NRF1 DOCK10 ARHGEF12 CASP8 APOE PNKD ARVCF MRPS14 ENO1 | 7.37e-04 | 952 | 237 | 18 | EFO_0007985 |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 7.38e-04 | 239 | 237 | 8 | EFO_0010934 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 7.54e-04 | 51 | 237 | 4 | EFO_0022242 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 8.05e-04 | 23 | 237 | 3 | OBA_2045181 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 8.05e-04 | 23 | 237 | 3 | OBA_2045158 | |
| Disease | neutrophil count | IKZF1 DGKH SSR2 SNX13 FANCA GLG1 RABGAP1L AFF1 RPRD2 AP3D1 SMG6 CUX2 RAPSN NUP88 ARHGEF12 MUS81 PNKD CIT ARVCF MRPS14 PRKDC ENO1 CCDC63 | 8.13e-04 | 1382 | 237 | 23 | EFO_0004833 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 8.50e-04 | 91 | 237 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 8.73e-04 | 53 | 237 | 4 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 8.73e-04 | 53 | 237 | 4 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 9.37e-04 | 54 | 237 | 4 | EFO_0022244 | |
| Disease | Emery-Dreifuss muscular dystrophy | 9.43e-04 | 6 | 237 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 9.43e-04 | 6 | 237 | 2 | C0410189 | |
| Disease | BMI-adjusted waist-hip ratio, forced expiratory volume | 9.43e-04 | 6 | 237 | 2 | EFO_0004314, EFO_0007788 | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 9.43e-04 | 6 | 237 | 2 | OBA_2045106 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 9.43e-04 | 6 | 237 | 2 | OBA_2045160 | |
| Disease | level of Phosphatidylcholine (16:0_18:0) in blood serum | 9.43e-04 | 6 | 237 | 2 | OBA_2045069 | |
| Disease | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 9.43e-04 | 6 | 237 | 2 | EFO_0020014 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 9.43e-04 | 6 | 237 | 2 | EFO_0800611 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 9.43e-04 | 6 | 237 | 2 | EFO_0801920 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLALLAVYTRRKLDA | 771 | Q86US8 | |
| DTTEKLRNTLDYLRS | 171 | Q92564 | |
| RTAYLDLLRLIRKDA | 606 | Q99424 | |
| DLLRLKDYQRRLDLS | 611 | Q92888 | |
| LLRDADDLQKRLAVY | 166 | P02649 | |
| LSLDRRNKDLIGSYA | 736 | O00192 | |
| SYRILLETKESLDNR | 526 | Q9NQ75 | |
| LYSVLLAENAKLRTE | 816 | Q8N5R6 | |
| AILRELDVENAKLYL | 636 | P45844 | |
| DATDYRLRSLRKLLA | 466 | Q6L9W6 | |
| LLQVTYRDSKEKRDL | 51 | Q5T601 | |
| TVLLREEKYASSRLL | 391 | Q5T601 | |
| EELRSLVQKRYELLE | 516 | Q9UIG0 | |
| SLLQEKRFLRDYDAL | 356 | Q9H1I8 | |
| RQSLEYDLAVARKEA | 81 | Q6TFL3 | |
| ERLRRTLTDYQNKLE | 456 | Q6TFL3 | |
| QLYIKSELDRELQDR | 1051 | Q6V0I7 | |
| SDLLDQYRSLLVERN | 226 | Q2M329 | |
| RQTVALELLESERKY | 266 | A8MVX0 | |
| LLYESTKDFLQLRSE | 281 | Q9BR77 | |
| LKYLEDDLLLRLSAA | 3646 | Q96DT5 | |
| LLVDRLEKESYLESR | 186 | Q9ULD4 | |
| DASERGRLLYKLADL | 81 | P00352 | |
| KRLDLSYNRIGLLDS | 71 | Q86SJ2 | |
| NDLALKLLRDYSADD | 2641 | P11532 | |
| LRLLQLATASIDRYE | 3031 | Q96M86 | |
| SRYRINLEDETQDLK | 1246 | Q9UPS8 | |
| EARALLEKNRSYRLL | 86 | O60231 | |
| LEKNRSYRLLEDSEE | 91 | O60231 | |
| ATQAELLELRRKYDE | 216 | O14529 | |
| LRERQLYKLLSEDFL | 266 | Q9BXF3 | |
| LLKTERSDLEYQLEN | 1186 | O14578 | |
| DLVDQRLISELRKEY | 691 | Q76M96 | |
| RLEDYQRRLDTSSLK | 986 | Q9NZN5 | |
| NRDKTIDLYTLLLED | 1031 | Q9NZN5 | |
| DKDESIRLRALDLLY | 351 | O14617 | |
| VTELRRKYTELQLEA | 831 | Q5T8P6 | |
| SGLLYTKQRIDRESL | 81 | O14917 | |
| LSESIYRSKGLQREL | 331 | Q13702 | |
| ELYKLTTERERLLTN | 86 | Q68DA7 | |
| EEREKSNRSELYLDL | 666 | Q68DA7 | |
| LELLRRYLENGKETL | 186 | P30511 | |
| LLASLYRDRIQSALE | 221 | P57740 | |
| SAKEYRQRSLLEKEL | 361 | Q32P28 | |
| RTLYRSDQLEELEKI | 276 | O60393 | |
| VRELDRELKSSYELQ | 201 | Q9HCL0 | |
| REKRDNYLLTITATD | 2986 | Q14517 | |
| LQELASIYSLKRLDA | 151 | Q8N4N3 | |
| LNDRLASYLEKVRSL | 96 | Q6A162 | |
| SKYESELSLRQLLEA | 176 | Q6A162 | |
| RLASYLDKVRALEES | 156 | P13645 | |
| LLESAANKTIIYLDR | 2626 | Q9NU22 | |
| DLRYLELISSIEERK | 671 | Q9HBG6 | |
| RLELDALRSKYEALQ | 101 | O60675 | |
| YEAKLSDLRARLQEA | 2031 | Q16787 | |
| IAIEYKSANRESRIL | 631 | Q12791 | |
| LERYLGALREAKNDS | 36 | Q9UBB6 | |
| DSGYRARISQLEKEL | 696 | Q8IWI9 | |
| LTELKAVLERQESYR | 311 | Q9UHH9 | |
| KRYSDIFRSLDNLEI | 16 | Q9P107 | |
| NCRKDSLSQLEEYLR | 686 | O60303 | |
| YRESKLTRILQDSLG | 311 | P52732 | |
| LEKRYLAAQREATSI | 301 | O75335 | |
| LKRYLDGLTAERTSQ | 236 | P35908 | |
| LYRLRDSDEIKEITL | 691 | Q8IYD8 | |
| LNDRLASYLEKVRAL | 111 | P13646 | |
| KTNLRRTTYLVLDEA | 236 | P17844 | |
| AALLLNRSESDIRYL | 21 | Q9UK73 | |
| IETYLLEKSRAIRQA | 281 | Q7Z406 | |
| KYRQEILTALDRDAS | 1836 | P51805 | |
| KYTLNDNRLLREDVE | 1731 | O43157 | |
| EYDLLSKRLTAELLR | 261 | Q6ZWH5 | |
| RDISAYEELVSKLNL | 476 | Q6ZWH5 | |
| SLAAAKQLLRYRLAE | 26 | O60245 | |
| LTYQTEEDRKNILRL | 1856 | Q9UKX2 | |
| IQAIELEDLLRYSKL | 241 | P21810 | |
| EKRRSINLSELIDVY | 366 | A2RU67 | |
| LELYLSDSLRNLNKE | 516 | Q9H4H8 | |
| QKIRSRYLEDTDRNL | 521 | Q9Y4A8 | |
| SLRTNATRALLLYLD | 56 | Q9P2S2 | |
| LLRKLRATLDEYTTR | 111 | Q16656 | |
| LEEVYSLQRLKARIS | 1851 | Q9HD67 | |
| RELETAYSNLLRDKS | 136 | Q99972 | |
| LQRSSEEKILYSDRL | 81 | Q8IUZ0 | |
| EEKILYSDRLSLERQ | 86 | Q8IUZ0 | |
| IDRLEELQSFLLYKN | 256 | Q9BYS8 | |
| ELTKERDALSLELYR | 201 | Q8N9W4 | |
| LTKERDALSLELYRN | 186 | A8MZA4 | |
| KERDALSLELYRNTI | 151 | H0YM25 | |
| KTRLEQEIATYRSLL | 396 | P19012 | |
| ISKDRRYADLTEDQL | 136 | Q8N0Y7 | |
| LSYSDSDLKRAENLL | 391 | A2A3K4 | |
| KLADVYQAELRELRL | 111 | P14136 | |
| LSLKEEHRAYDLLRA | 426 | Q13422 | |
| LGTRELLQRSYKNLE | 811 | Q86XP1 | |
| LKDRALYAQDALRVL | 441 | Q5TGP6 | |
| NLNDRLASYLEKVRT | 76 | P35900 | |
| ENVRKLSRADLTEYL | 206 | P31930 | |
| SKRLLSDDRSNILIY | 146 | Q92643 | |
| RSYVDLLKLEDVLRQ | 536 | Q9BXJ9 | |
| KSLDLTYDRRLSDDQ | 176 | A6NCF6 | |
| LDRYRILITKDSAQE | 561 | Q5R372 | |
| GTREDDKYRLDLLTQ | 251 | P20839 | |
| VSRDKSFLLDRLLQY | 46 | Q8NBZ0 | |
| SYLAVRLKDQDLRDS | 171 | Q9UMY1 | |
| INYRDSKLTRLLKDS | 296 | Q2TAC6 | |
| EDSVRKYLLQARTAI | 5976 | Q5VST9 | |
| SDLDKAYQELLRLIN | 646 | Q8N3R9 | |
| READLLEDIRSYSKQ | 31 | Q86WN1 | |
| LEDIRSYSKQRAAIE | 36 | Q86WN1 | |
| ELKDIEDQILYRLSS | 3386 | Q9P2D7 | |
| RRFESAQEKLLETLY | 521 | P0DPD8 | |
| YGRESELLATRQDLK | 1036 | Q15075 | |
| SERLAKYNQLLRIEE | 401 | P06733 | |
| LKLRYADQRLSSDCE | 971 | Q92896 | |
| ESLTEAYKLRAARLV | 481 | Q15067 | |
| RVLAYSRLKELTLED | 111 | P08571 | |
| LDKLLRYDHQSRLTA | 301 | Q8NEV1 | |
| RYLEKLLLATSRNDV | 31 | Q86XA9 | |
| YRLAELFDLSRLTEQ | 156 | Q53GT1 | |
| LNDRLASYLDKVRAL | 91 | Q04695 | |
| EKKTNDLLLLETYRR | 451 | Q8NA47 | |
| LRLLSEDTDSQRLAY | 231 | Q01094 | |
| SVALYDLRDSRKISA | 426 | Q96BY6 | |
| LRRSLKTILTYAEED | 1616 | Q96N67 | |
| RSLLLDSTQRLEKIY | 436 | Q9H799 | |
| KRELARAQDDYISLD | 146 | P16383 | |
| ELRSDLVLLYELKQA | 366 | Q9NPF5 | |
| LLTDYISLAKTRLAD | 506 | O15360 | |
| LAYSQSAEELLRRRK | 51 | Q5JPI3 | |
| ASDEDLKKAYRRLAL | 121 | Q9NXW2 | |
| VKLKERNDRETYSLL | 1831 | Q8WXX0 | |
| EEEFRTIYLNTLLRK | 241 | Q9UBX1 | |
| AAKEALYRRNLVESE | 931 | Q6P1N0 | |
| ALLSSRQREYKVAAL | 281 | Q5T0F9 | |
| YDLATKRVRQLLDLD | 261 | Q9H4A6 | |
| LLQLSYEIELRKHRD | 386 | Q68CZ6 | |
| RLDLLITYLNTRKEE | 71 | Q14790 | |
| LDKLLRYDHQSRLTA | 301 | P68400 | |
| AADRQAALTKLRYSL | 441 | Q96RQ3 | |
| DLYLERLRLTESDKL | 356 | O95466 | |
| YSKERFSLLLLNLEE | 16 | Q92636 | |
| LRRKYDRGLLSDEDL | 106 | Q96LL9 | |
| LYSSNLRDDTKAILE | 1031 | Q6ZRV2 | |
| LSLTSTLYLRLRKDD | 216 | P50895 | |
| QALIEELLLYKRSED | 191 | Q5VT52 | |
| LDREEKSLYILRAKA | 116 | Q9ULB4 | |
| AIQKLDREERSLYIL | 101 | Q9H159 | |
| ISKDRRYADLTEDQL | 136 | P18669 | |
| RDYLIKIIDDSDSNL | 706 | P0DJD0 | |
| LSLSAARYALLRLEE | 671 | Q9H2X9 | |
| ESIETKRARLLYESR | 61 | Q9NX18 | |
| RSARELYLSAKVEAL | 41 | Q9BTL4 | |
| QLEDLSYCREERKSL | 601 | Q99567 | |
| SRNLEYARLRKIADE | 206 | P34896 | |
| ILNEITKEDLRYLRL | 1271 | Q6ZN16 | |
| NLYSDLKNLDSRIRA | 591 | Q6NUM9 | |
| SLQELKERALSRYNL | 321 | Q9NVX2 | |
| VRDKAAEELQYLRSL | 306 | Q9Y5W8 | |
| ASRAIDLLKEIYTNL | 786 | Q93008 | |
| TLLQDLADKYRRAAR | 76 | Q8IUD6 | |
| AELQRYILATLLKED | 546 | Q6PI48 | |
| YLKSSDRLDEAAQRL | 186 | Q9HCS7 | |
| QSTKAVYDRILDLRI | 501 | Q9HCS7 | |
| LEKEEQQTLSRLRDY | 201 | O00635 | |
| SYEKSELSLDRLRTL | 1181 | O95602 | |
| YSRAQLLEELRRLKD | 366 | Q8N490 | |
| EIARQLTLLESDLYR | 781 | Q07890 | |
| VNSLFLTDLYRDRKL | 161 | O43236 | |
| LLNTTDYRILLKDED | 51 | Q13275 | |
| DASSLYRNILEKERE | 751 | Q9H5Y7 | |
| LALALQERKYAIEDL | 4281 | Q8NF91 | |
| LSYREALERLEQSKA | 3391 | Q8WXH0 | |
| NLTKELELSKRYSRA | 771 | Q7Z7B0 | |
| LASTRRDYEKIQEEL | 456 | O60282 | |
| NDRLASYLEKVRQLE | 106 | O76011 | |
| ENYIRDRLALSLKEN | 466 | Q8N4C6 | |
| ERLYAQKSRIQDELS | 51 | Q96GI7 | |
| YLDDLRSKFLLENSV | 421 | Q92696 | |
| ELRSFLQVRKYSLDL | 506 | Q05397 | |
| QELVRDYLELEKRLS | 211 | Q96MH2 | |
| LLTSSKDRELLEYRN | 476 | Q9NXP7 | |
| DEIRKNTYRTLDSLE | 1656 | Q5T5P2 | |
| TRLDSSNLEKIYREV | 61 | A0A0B4J2F2 | |
| TRLDSSNLEKIYREV | 61 | P57059 | |
| LNRYSSLKRLAEKDL | 316 | A6NL88 | |
| LLSIDYDRNIRTEKI | 1846 | Q9NT68 | |
| AIKARNEYLLALEAT | 246 | P0DMP2 | |
| LTYQSEEDRKNVLRL | 1851 | P11055 | |
| DYQESGATLIRDRLK | 166 | Q9H9Q4 | |
| IVYRDLKLDNLLLDT | 736 | Q16512 | |
| SLEYKALEQRFLELL | 921 | Q9BZV3 | |
| RSRSEYLNRLKKDLA | 261 | P46087 | |
| SVDERKLRELTQRYL | 241 | Q9H0A9 | |
| KLRELTQRYLALSAR | 246 | Q9H0A9 | |
| DRDVQLSKALSYALR | 26 | Q86TN4 | |
| IRYRKELINNLDADS | 246 | Q8N5C6 | |
| YQEELSRELSKTRSL | 2166 | Q9H2D6 | |
| RLEKLDSLLSDYDIL | 31 | P78536 | |
| SLYNDDRNLLRIREK | 6 | P51825 | |
| LIERDRTYLAALETL | 111 | P05091 | |
| SRLSKELLAEYQDLT | 6 | Q99828 | |
| LDQYRASLVDAIKRL | 236 | Q7Z624 | |
| REEKLGDSLQDLYRA | 901 | Q8WXI2 | |
| IETYLLEKSRAIRQA | 261 | P35749 | |
| QYLAVERSLDLDISK | 326 | P42765 | |
| KRLDDSLLYLRDALP | 181 | P49406 | |
| LKSIIQEVARDYRDL | 266 | Q96JJ7 | |
| ELFARYDRLLLQSSL | 286 | Q9UBS8 | |
| LRYHLEESRDKNVLL | 901 | Q9NR97 | |
| EYADERLRINSLRKN | 46 | O60783 | |
| SKSLLNRYAVEGRDL | 26 | P43308 | |
| ELGLLDLAQRKLYRD | 21 | Q9UK11 | |
| KEQRLALALDEYVRL | 121 | Q6AWC2 | |
| NLLGLIYDEETKRRL | 1301 | Q8N2C7 | |
| DRRLRKTILALEYSS | 541 | Q5GH72 | |
| KVLARNLYSLDLSDL | 671 | Q6GYQ0 | |
| EEAARRISELKSYLS | 1051 | Q99973 | |
| QELYRSVSRKSLLFD | 416 | Q9NZQ8 | |
| LLETERKRLASNYLN | 316 | Q96EK2 | |
| LAVLLAAKELSDRYR | 271 | Q9H2B4 | |
| LSLDRENSYRLLKLA | 126 | P38935 | |
| DNLLAAADKYALERL | 271 | Q6IQ16 | |
| SRDALSLEEILRLYN | 36 | Q08AE8 | |
| ELDNLLHEKRYLRAL | 656 | Q12788 | |
| ELSTLRRQKLEDSYR | 31 | Q13813 | |
| LLLYRLDRSINKELD | 61 | Q5T4T6 | |
| AIKARNEYLLALEAT | 246 | O75044 | |
| KILVTSNDSRIRLYD | 756 | Q5JSH3 | |
| IESYKQDRDIALLDL | 106 | Q8WVM7 | |
| NLEAARILVKDESLY | 126 | Q5VVX9 | |
| DQKLLLDLFRFLDRT | 236 | Q9H9C1 | |
| IDTYRDLKDRQQLLA | 451 | Q9H9C1 | |
| NSRLRDYRSLIEKDV | 401 | Q8TC07 | |
| YLEADSQLKLRVDIA | 171 | Q6ZUG5 | |
| ENRELYIKTTLRELL | 91 | Q9P0L9 | |
| KLYLNETFSELRLDS | 1556 | P27708 | |
| LLLDQSELRSIYLDK | 266 | Q9BQ16 | |
| LSLLYLLQDDVDRAK | 3086 | P78527 | |
| SKLYRAALETDENLL | 486 | O75643 | |
| ELGLLDSVQRKLYRD | 21 | Q9UJU3 | |
| RDRFSDFLLTKLRDL | 321 | Q9H6S0 | |
| KLYRRLSEVLGLNDE | 571 | Q9UIA9 | |
| ELRLLDLTQRKLYRD | 36 | Q86WZ6 | |
| QLSRTTEKELLIYLR | 281 | P21731 | |
| LYLSEQLRVEKASRD | 56 | O15482 | |
| ELGLLDLAQRKLYRD | 21 | Q9NZL3 | |
| EEDVLYNISRRLSKL | 1366 | O15050 | |
| AILRRAELYEKTDKL | 191 | Q99614 | |
| ELGLLDSAQRKLYRD | 21 | Q14590 | |
| RALDLKTLYLTENQE | 616 | Q9UPU7 | |
| LELQAASSRELIRKY | 881 | Q70J99 | |
| SLELATRLDSRLYAL | 421 | Q9UGI0 | |
| LEQLKAEYLERRASR | 896 | Q9BYX2 | |
| ELGLLDVSQRKLYRD | 21 | Q2VY69 | |
| YLASAERAALAKALR | 181 | O43763 | |
| LKASAADREIYLLRT | 551 | Q9C099 | |
| IYNSETEKLRSDLER | 956 | Q9Y4I1 | |
| RTADIKESAAYLALL | 401 | Q96NY9 | |
| KSLQLRLEDETILEY | 36 | Q9ULV0 | |
| RYQDLQEKLLLSEAT | 1226 | Q5VU43 | |
| KLSLYVADENRELAL | 46 | Q96PU5 |